SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'MET'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1A29_A_TFPA154_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		5 / 10 LEU D  18
MET D 109
GLU D 114
LEU D 116
MET D 124
 LEU  D  18 ( 0.6A)
MET  D 109 ( 0.0A)
GLU  D 114 ( 0.6A)
LEU  D 116 ( 0.6A)
MET  D 124 ( 0.0A)
 1.27A 1a29A-4gowD:
14.6		 1a29A-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1A29_A_TFPA154_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		5 / 10 MET D 109
LEU D 116
GLU D 120
GLU D 123
MET D 124
 MET  D 109 ( 0.0A)
LEU  D 116 ( 0.6A)
GLU  D 120 ( 0.6A)
GLU  D 123 ( 0.6A)
MET  D 124 ( 0.0A)
 1.12A 1a29A-4gowD:
14.6		 1a29A-4gowD:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_A_DCFA353_1
(ADENOSINE DEAMINASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 PHE A  50
ALA A 185
HIS A 153
HIS A 161
ASP A  82
 MET  A1298 (-3.8A)
MN  A 296 ( 3.9A)
MN  A 296 ( 3.3A)
MET  A1298 (-4.0A)
MN  A 297 ( 1.7A)
 1.23A 1a4lA-1wkmA:
undetectable		 1a4lA-1wkmA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_B_DCFB853_1
(ADENOSINE DEAMINASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 PHE A  50
ALA A 185
HIS A 153
HIS A 161
ASP A  82
 MET  A1298 (-3.8A)
MN  A 296 ( 3.9A)
MN  A 296 ( 3.3A)
MET  A1298 (-4.0A)
MN  A 297 ( 1.7A)
 1.24A 1a4lB-1wkmA:
undetectable		 1a4lB-1wkmA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_C_DCFC1353_1
(ADENOSINE DEAMINASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 PHE A  50
ALA A 185
HIS A 153
HIS A 161
ASP A  82
 MET  A1298 (-3.8A)
MN  A 296 ( 3.9A)
MN  A 296 ( 3.3A)
MET  A1298 (-4.0A)
MN  A 297 ( 1.7A)
 1.21A 1a4lC-1wkmA:
undetectable		 1a4lC-1wkmA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_D_DCFD1853_1
(ADENOSINE DEAMINASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 PHE A  50
ALA A 185
HIS A 153
HIS A 161
ASP A  82
 MET  A1298 (-3.8A)
MN  A 296 ( 3.9A)
MN  A 296 ( 3.3A)
MET  A1298 (-4.0A)
MN  A 297 ( 1.7A)
 1.30A 1a4lD-1wkmA:
undetectable		 1a4lD-1wkmA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ACL_A_DMEA999_1
(ACETYLCHOLINESTERASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 10 TYR A 263
TYR A 265
GLU A 187
HIS A 153
GLY A 152
 None
MET  A1298 ( 4.7A)
MN  A 296 ( 2.6A)
MN  A 296 ( 3.3A)
None
 1.31A 1aclA-1wkmA:
undetectable		 1aclA-1wkmA:
19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AM6_A_HAEA555_1
(CARBONIC ANHYDRASE)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 7 HIS A 237
HIS A 235
HIS A 255
LEU A 202
 MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MET  A 600 (-3.7A)
 0.87A 1am6A-2qs8A:
undetectable		 1am6A-2qs8A:
23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AM6_A_HAEA555_1
(CARBONIC ANHYDRASE)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 7 HIS A 255
HIS A 237
HIS A 235
LEU A 202
 MET  A 600 ( 4.3A)
MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 (-3.7A)
 0.97A 1am6A-2qs8A:
undetectable		 1am6A-2qs8A:
23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AZM_A_AZMA262_1
(CARBONIC ANHYDRASE I)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 HIS A 237
HIS A 235
HIS A 255
LEU A 202
 MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MET  A 600 (-3.7A)
 0.83A 1azmA-2qs8A:
undetectable		 1azmA-2qs8A:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AZM_A_AZMA262_1
(CARBONIC ANHYDRASE I)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 HIS A 255
HIS A 237
HIS A 235
LEU A 202
 MET  A 600 ( 4.3A)
MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 (-3.7A)
 0.96A 1azmA-2qs8A:
undetectable		 1azmA-2qs8A:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BZM_A_MZMA262_1
(CARBONIC ANHYDRASE I)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 HIS A 237
HIS A 235
HIS A 255
LEU A 202
 MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MET  A 600 (-3.7A)
 0.80A 1bzmA-2qs8A:
undetectable		 1bzmA-2qs8A:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BZM_A_MZMA262_1
(CARBONIC ANHYDRASE I)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 HIS A 255
HIS A 237
HIS A 235
LEU A 202
 MET  A 600 ( 4.3A)
MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 (-3.7A)
 0.97A 1bzmA-2qs8A:
undetectable		 1bzmA-2qs8A:
20.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CTR_A_TFPA153_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 9 ILE D 100
GLU D 123
GLU D 127
ALA D 128
VAL D 136
MET D 144
 ILE  D 100 ( 0.7A)
GLU  D 123 ( 0.6A)
GLU  D 127 ( 0.6A)
ALA  D 128 ( 0.0A)
VAL  D 136 ( 0.6A)
MET  D 144 ( 0.0A)
 1.27A 1ctrA-4gowD:
17.2		 1ctrA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CTR_A_TFPA153_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 9 ILE D 100
LEU D 105
GLU D 127
ALA D 128
VAL D 136
MET D 144
 ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
GLU  D 127 ( 0.6A)
ALA  D 128 ( 0.0A)
VAL  D 136 ( 0.6A)
MET  D 144 ( 0.0A)
 1.00A 1ctrA-4gowD:
17.2		 1ctrA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CTR_A_TFPA153_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 9 ILE D 100
LEU D 105
MET D 124
GLU D 127
ALA D 128
VAL D 136
 ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 124 ( 0.0A)
GLU  D 127 ( 0.6A)
ALA  D 128 ( 0.0A)
VAL  D 136 ( 0.6A)
 0.71A 1ctrA-4gowD:
17.2		 1ctrA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 11 ILE D 100
LEU D 105
MET D 109
LEU D 112
MET D 124
MET D 144
 ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
LEU  D 112 ( 0.6A)
MET  D 124 ( 0.0A)
MET  D 144 ( 0.0A)
 0.96A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 11 ILE D 100
LEU D 105
MET D 109
LEU D 112
MET D 124
MET D 145
 ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
LEU  D 112 ( 0.6A)
MET  D 124 ( 0.0A)
MET  D 145 ( 0.0A)
 1.33A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 11 ILE D 100
LEU D 105
MET D 109
LEU D 112
MET D 145
LEU D  18
 ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
LEU  D 112 ( 0.6A)
MET  D 145 ( 0.0A)
LEU  D  18 ( 0.6A)
 1.35A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		8 / 11 PHE D  19
ILE D  27
LEU D  32
MET D  36
LEU D  39
MET D  51
VAL D  55
MET D  71
 PHE  D  19 ( 1.3A)
ILE  D  27 ( 0.7A)
LEU  D  32 ( 0.6A)
MET  D  36 ( 0.0A)
LEU  D  39 ( 0.5A)
MET  D  51 ( 0.0A)
VAL  D  55 ( 0.6A)
MET  D  71 ( 0.0A)
 0.74A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 11 PHE D  92
ILE D 100
LEU D 105
LEU D 112
MET D 124
MET D 144
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
LEU  D 112 ( 0.6A)
MET  D 124 ( 0.0A)
MET  D 144 ( 0.0A)
 0.79A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 11 PHE D  92
ILE D 100
LEU D 105
LEU D 112
MET D 124
MET D 145
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
LEU  D 112 ( 0.6A)
MET  D 124 ( 0.0A)
MET  D 145 ( 0.0A)
 1.26A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 11 PHE D  92
ILE D 100
LEU D 105
LEU D 112
MET D 145
LEU D  18
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
LEU  D 112 ( 0.6A)
MET  D 145 ( 0.0A)
LEU  D  18 ( 0.6A)
 1.29A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA206_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		4 / 8 MET D  36
GLN D  41
PRO D  43
GLU D  47
 MET  D  36 ( 0.0A)
GLN  D  41 ( 0.6A)
PRO  D  43 ( 1.1A)
GLU  D  47 ( 0.5A)
 1.06A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E9L_A_GCSA800_1
(YM1 SECRETORY
PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		8 / 9 TYR A 156
PHE A 184
GLY A 267
ASP A 306
MET A 381
TYR A 383
ASP A 384
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TRP  A 532 ( 0.5A)
 0.84A 1e9lA-5gprA:
42.6		 1e9lA-5gprA:
23.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EE2_B_CHDB1250_0
(ALCOHOL
DEHYDROGENASE)		 5c6d UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 7
(Homo
sapiens) 		3 / 3 MET A 648
LEU A 651
SER A 652
 MET  A 648 ( 0.0A)
LEU  A 651 ( 0.5A)
SER  A 652 ( 0.0A)
 0.65A 1ee2A-5c6dA:
undetectable		 1ee2A-5c6dA:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ERE_A_ESTA600_1
(ESTROGEN RECEPTOR)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		5 / 9 ALA A 276
LEU A 175
LEU A 178
ILE A 289
HIS A 270
 None
None
None
None
MET  A 600 (-4.6A)
 1.18A 1ereA-2x1mA:
undetectable		 1ereA-2x1mA:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ERR_B_CCSB381_0
(ESTROGEN RECEPTOR)		 3tqw METHIONINE-BINDING
PROTEIN
(Coxiella
burnetii) 		3 / 3 GLU A  11
ALA A   8
SER A  36
 MET  A 238 (-3.2A)
None
None
 0.70A 1errB-3tqwA:
undetectable		 1errB-3tqwA:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FDS_A_ESTA350_1
(17-BETA-HYDROXYSTERO
ID-DEHYDROGENASE)		 5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE
(Bacillus
licheniformis) 		5 / 12 LEU A 150
GLY A  86
SER A 233
PHE A 236
MET A 162
 LEU  A 150 ( 0.6A)
GLY  A  86 ( 0.0A)
SER  A 233 ( 0.0A)
PHE  A 236 ( 1.3A)
MET  A 162 ( 0.0A)
 1.42A 1fdsA-5xluA:
undetectable		 1fdsA-5xluA:
13.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FWE_C_HAEC989_1
(UREASE)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		5 / 6 HIS A  69
HIS A  71
HIS A 235
HIS A 255
ASP A 328
 MG  A 500 (-3.6A)
MG  A 500 (-3.4A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MG  A 500 ( 2.8A)
 0.90A 1fweC-2qs8A:
19.5		 1fweC-2qs8A:
22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FWE_C_HAEC989_1
(UREASE)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		5 / 6 HIS A  69
HIS A 150
HIS A 235
HIS A 255
ASP A 328
 MG  A 500 (-3.6A)
MET  A 600 (-4.1A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MG  A 500 ( 2.8A)
 1.24A 1fweC-2qs8A:
19.5		 1fweC-2qs8A:
22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1H7X_B_URFB1033_1
(DIHYDROPYRIMIDINE
DEHYDROGENASE)		 1xs5 MEMBRANE LIPOPROTEIN
TPN32
(Treponema
pallidum) 		4 / 6 ILE A 174
ASN A 175
SER A 159
ASN A 116
 None
MET  A 301 (-3.8A)
None
MET  A 301 (-3.6A)
 1.25A 1h7xB-1xs5A:
undetectable		 1h7xB-1xs5A:
12.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1H7X_D_URFD1033_1
(DIHYDROPYRIMIDINE
DEHYDROGENASE)		 1xs5 MEMBRANE LIPOPROTEIN
TPN32
(Treponema
pallidum) 		4 / 6 ILE A 174
ASN A 175
SER A 159
ASN A 116
 None
MET  A 301 (-3.8A)
None
MET  A 301 (-3.6A)
 1.26A 1h7xD-1xs5A:
undetectable		 1h7xD-1xs5A:
12.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HK3_A_T44A3004_1
(SERUM ALBUMIN)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		4 / 7 LEU A 366
VAL A 506
MET A 509
LEU A 354
 LEU  A 366 ( 0.6A)
VAL  A 506 ( 0.6A)
MET  A 509 ( 0.0A)
LEU  A 354 ( 0.6A)
 0.98A 1hk3A-2vbfA:
undetectable		 1hk3A-2vbfA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HK3_A_T44A3004_1
(SERUM ALBUMIN)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 GLU A 256
VAL A 338
MET A 339
LEU A 239
 GLU  A 256 ( 0.6A)
VAL  A 338 ( 0.6A)
MET  A 339 ( 0.0A)
LEU  A 239 ( 0.6A)
 0.83A 1hk3A-3o96A:
1.6		 1hk3A-3o96A:
21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IIU_A_RTLA176_0
(PLASMA
RETINOL-BINDING
PROTEIN)		 3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A
(Pyrococcus
furiosus;
Saccharomyces
cerevisiae) 		5 / 11 LEU A 220
ALA A 236
ALA A 232
MET A 231
LEU A 186
 LEU  A 220 ( 0.5A)
ALA  A 236 ( 0.0A)
ALA  A 232 ( 0.0A)
MET  A 231 ( 0.0A)
LEU  A 186 (-0.6A)
 1.11A 1iiuA-3whlA:
undetectable		 1iiuA-3whlA:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ITU_A_CILA451_1
(RENAL DIPEPTIDASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 ASP A  82
GLU A 187
HIS A 153
TYR A 265
PRO A  51
 MN  A 297 ( 1.7A)
MN  A 296 ( 2.6A)
MN  A 296 ( 3.3A)
MET  A1298 ( 4.7A)
None
 1.14A 1ituA-1wkmA:
undetectable		 1ituA-1wkmA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ITU_A_CILA451_1
(RENAL DIPEPTIDASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 ASP A  82
HIS A 153
HIS A 161
TYR A 265
PRO A  51
 MN  A 297 ( 1.7A)
MN  A 296 ( 3.3A)
MET  A1298 (-4.0A)
MET  A1298 ( 4.7A)
None
 1.43A 1ituA-1wkmA:
undetectable		 1ituA-1wkmA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ITU_B_CILB452_1
(RENAL DIPEPTIDASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 ASP A  82
GLU A 187
HIS A 153
TYR A 265
PRO A  51
 MN  A 297 ( 1.7A)
MN  A 296 ( 2.6A)
MN  A 296 ( 3.3A)
MET  A1298 ( 4.7A)
None
 1.18A 1ituB-1wkmA:
undetectable		 1ituB-1wkmA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ITU_B_CILB452_1
(RENAL DIPEPTIDASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 ASP A  82
HIS A 153
HIS A 161
TYR A 265
PRO A  51
 MN  A 297 ( 1.7A)
MN  A 296 ( 3.3A)
MET  A1298 (-4.0A)
MET  A1298 ( 4.7A)
None
 1.42A 1ituB-1wkmA:
undetectable		 1ituB-1wkmA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JDV_E_ADNE4260_1
(5'-METHYLTHIOADENOSI
NE PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 12 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.69A 1jdvE-4g41A:
23.8
1jdvF-4g41A:
23.7		 1jdvE-4g41A:
24.70
1jdvF-4g41A:
24.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JDV_E_ADNE4260_1
(5'-METHYLTHIOADENOSI
NE PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 12 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.81A 1jdvE-4g41A:
23.8
1jdvF-4g41A:
23.7		 1jdvE-4g41A:
24.70
1jdvF-4g41A:
24.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KT5_A_RTLA176_0
(PLASMA
RETINOL-BINDING
PROTEIN)		 3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A
(Pyrococcus
furiosus;
Saccharomyces
cerevisiae) 		5 / 12 LEU A 220
ALA A 236
ALA A 232
MET A 231
LEU A 186
 LEU  A 220 ( 0.5A)
ALA  A 236 ( 0.0A)
ALA  A 232 ( 0.0A)
MET  A 231 ( 0.0A)
LEU  A 186 (-0.6A)
 1.13A 1kt5A-3whlA:
undetectable		 1kt5A-3whlA:
19.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LXF_C_BEPC92_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 4gow CALMODULIN
(Homo
sapiens) 		7 / 12 ILE D 100
LEU D 105
MET D 109
MET D 124
ILE D 125
VAL D 136
MET D 145
 ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
MET  D 124 ( 0.0A)
ILE  D 125 ( 0.4A)
VAL  D 136 ( 0.6A)
MET  D 145 ( 0.0A)
 1.07A 1lxfC-4gowD:
9.8		 1lxfC-4gowD:
67.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LXF_C_BEPC92_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 4gow CALMODULIN
(Homo
sapiens) 		7 / 12 LEU D 105
MET D 109
MET D 124
ILE D 125
VAL D 136
MET D 144
MET D 145
 LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
MET  D 124 ( 0.0A)
ILE  D 125 ( 0.4A)
VAL  D 136 ( 0.6A)
MET  D 144 ( 0.0A)
MET  D 145 ( 0.0A)
 1.31A 1lxfC-4gowD:
9.8		 1lxfC-4gowD:
67.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LXF_C_BEPC92_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 4gow CALMODULIN
(Homo
sapiens) 		7 / 12 PHE D  92
ILE D 100
LEU D 105
MET D 124
ILE D 125
VAL D 136
MET D 145
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 124 ( 0.0A)
ILE  D 125 ( 0.4A)
VAL  D 136 ( 0.6A)
MET  D 145 ( 0.0A)
 0.78A 1lxfC-4gowD:
9.8		 1lxfC-4gowD:
67.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LXF_C_BEPC92_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 12 PHE D  92
LEU D 105
MET D 124
ILE D 125
GLU D 127
VAL D 136
 PHE  D  92 ( 1.3A)
LEU  D 105 ( 0.6A)
MET  D 124 ( 0.0A)
ILE  D 125 ( 0.4A)
GLU  D 127 ( 0.6A)
VAL  D 136 ( 0.6A)
 0.94A 1lxfC-4gowD:
9.8		 1lxfC-4gowD:
67.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MX1_D_THAD4_2
(LIVER
CARBOXYLESTERASE I)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		3 / 3 PHE A 318
LEU A 303
MET A 300
 PHE  A 318 ( 1.3A)
LEU  A 303 ( 0.6A)
MET  A 300 ( 0.0A)
 0.77A 1mx1D-2vbfA:
undetectable		 1mx1D-2vbfA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MX1_D_THAD4_2
(LIVER
CARBOXYLESTERASE I)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		3 / 3 PHE A 418
LEU A 270
MET A 275
 PHE  A 418 ( 1.3A)
LEU  A 270 ( 0.6A)
MET  A 275 ( 0.0A)
 0.84A 1mx1D-4kqnA:
undetectable		 1mx1D-4kqnA:
23.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MZ9_D_VDYD1001_5
(CARTILAGE OLIGOMERIC
MATRIX PROTEIN)		 1d6s O-ACETYLSERINE
SULFHYDRYLASE
(Salmonella
enterica) 		3 / 3 THR A  72
LEU A  76
VAL A  79
 MET  A 401 (-3.8A)
None
None
 0.65A 1mz9E-1d6sA:
undetectable		 1mz9E-1d6sA:
9.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4H_A_REAA500_1
(NUCLEAR RECEPTOR
ROR-BETA)		 1rrv GLYCOSYLTRANSFERASE
GTFD
(Amycolatopsis
orientalis) 		5 / 11 ALA A  21
VAL A  48
MET A  33
VAL A   7
ALA A  39
 ALA  A  21 ( 0.0A)
VAL  A  48 ( 0.6A)
MET  A  33 ( 0.0A)
VAL  A   7 ( 0.6A)
ALA  A  39 ( 0.0A)
 1.09A 1n4hA-1rrvA:
undetectable		 1n4hA-1rrvA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ODI_C_ADNC1238_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.92A 1odiC-4g41A:
23.2		 1odiC-4g41A:
27.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PG2_A_ADNA552_1
(METHIONYL-TRNA
SYNTHETASE)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		8 / 11 ALA A  10
GLY A  21
HIS A  22
GLU A  25
GLY A 263
ASP A 265
ILE A 266
HIS A 292
 MET  A 600 ( 3.9A)
None
None
None
None
None
MET  A 600 (-3.9A)
None
 0.62A 1pg2A-2x1mA:
38.1		 1pg2A-2x1mA:
27.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PG2_A_ADNA552_1
(METHIONYL-TRNA
SYNTHETASE)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		7 / 11 HIS A 256
GLY A 258
HIS A 259
GLY A 516
ASP A 518
ILE A 519
HIS A 545
 None
None
None
None
None
MET  A 807 ( 4.4A)
None
 0.60A 1pg2A-5nfhA:
34.3		 1pg2A-5nfhA:
27.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1PG2_A_ADNA552_1
(METHIONYL-TRNA
SYNTHETASE)		 5urb METHIONINE--TRNA
LIGASE
(Acinetobacter
baumannii) 		5 / 11 ALA A   9
GLY A  20
GLY A 292
ASP A 294
ILE A 295
 MET  A 603 ( 4.0A)
None
None
None
MET  A 603 (-4.3A)
 0.39A 1pg2A-5urbA:
52.9		 1pg2A-5urbA:
58.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_A_ADNA1245_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 9 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.64A 1pk7A-4g41A:
25.1		 1pk7A-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_C_ADNC1247_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 10 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.90A 1pk7C-4g41A:
24.6		 1pk7C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_C_ADNC1247_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.80A 1pk7C-4g41A:
24.6		 1pk7C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 10 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.74A 1pk9A-4g41A:
25.0		 1pk9A-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.66A 1pk9A-4g41A:
25.0		 1pk9A-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_B_2FAB307_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 9 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.72A 1pk9B-4g41A:
24.6		 1pk9B-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.91A 1pk9C-4g41A:
24.8		 1pk9C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.72A 1pk9C-4g41A:
24.8		 1pk9C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.74A 1pk9C-4g41A:
24.8		 1pk9C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PW7_A_RABA645_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 10 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.68A 1pw7A-4g41A:
25.1		 1pw7A-4g41A:
24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PW7_B_RABB646_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 9 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.71A 1pw7B-4g41A:
24.6		 1pw7B-4g41A:
24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PW7_C_RABC647_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 9 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.75A 1pw7C-4g41A:
24.7		 1pw7C-4g41A:
24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PW7_C_RABC647_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 9 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.69A 1pw7C-4g41A:
24.7		 1pw7C-4g41A:
24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QKU_A_ESTA600_1
(ESTRADIOL RECEPTOR)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		5 / 10 ALA A 276
LEU A 175
LEU A 178
ILE A 289
HIS A 270
 None
None
None
None
MET  A 600 (-4.6A)
 1.16A 1qkuA-2x1mA:
undetectable		 1qkuA-2x1mA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QKU_B_ESTB600_1
(ESTRADIOL RECEPTOR)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		5 / 10 ALA A 276
LEU A 175
LEU A 178
ILE A 289
HIS A 270
 None
None
None
None
MET  A 600 (-4.6A)
 1.15A 1qkuB-2x1mA:
undetectable		 1qkuB-2x1mA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QKU_C_ESTC600_1
(ESTRADIOL RECEPTOR)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		5 / 10 ALA A 276
LEU A 175
LEU A 178
ILE A 289
HIS A 270
 None
None
None
None
MET  A 600 (-4.6A)
 1.16A 1qkuC-2x1mA:
undetectable		 1qkuC-2x1mA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RLB_E_REAE176_1
(RETINOL BINDING
PROTEIN)		 3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A
(Pyrococcus
furiosus;
Saccharomyces
cerevisiae) 		5 / 10 LEU A 220
ALA A 236
ALA A 232
MET A 231
LEU A 186
 LEU  A 220 ( 0.5A)
ALA  A 236 ( 0.0A)
ALA  A 232 ( 0.0A)
MET  A 231 ( 0.0A)
LEU  A 186 (-0.6A)
 1.16A 1rlbE-3whlA:
undetectable		 1rlbE-3whlA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RLB_F_REAF177_1
(RETINOL BINDING
PROTEIN)		 3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A
(Pyrococcus
furiosus;
Saccharomyces
cerevisiae) 		5 / 11 LEU A 220
ALA A 236
ALA A 232
MET A 231
LEU A 186
 LEU  A 220 ( 0.5A)
ALA  A 236 ( 0.0A)
ALA  A 232 ( 0.0A)
MET  A 231 ( 0.0A)
LEU  A 186 (-0.6A)
 1.09A 1rlbF-3whlA:
undetectable		 1rlbF-3whlA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RXC_I_URFI2041_1
(URIDINE
PHOSPHORYLASE)		 4yah D-METHIONINE-BINDING
LIPOPROTEIN METQ
(Escherichia
coli) 		4 / 8 THR X 204
GLY X  40
ILE X  38
VAL X  39
 MET  X 301 (-4.0A)
None
None
None
 0.98A 1rxcI-4yahX:
undetectable		 1rxcI-4yahX:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SKX_A_RFPA1_2
(ORPHAN NUCLEAR
RECEPTOR PXR)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 5 PHE A 442
LEU A 486
MET A  79
LEU A 120
 PHE  A 442 ( 1.3A)
LEU  A 486 ( 0.6A)
MET  A  79 ( 0.0A)
LEU  A 120 ( 0.6A)
 1.10A 1skxA-3gnrA:
undetectable		 1skxA-3gnrA:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UPF_D_URFD999_1
(URACIL
PHOSPHORIBOSYLTRANSF
ERASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
RHOPTRY NECK PROTEIN
2
(Plasmodium
falciparum;
Plasmodium
vivax) 		4 / 4 MET B2045
ALA A 253
TYR A 251
ILE A 252
 MET  B2045 ( 0.0A)
ALA  A 253 ( 0.0A)
TYR  A 251 ( 1.3A)
ILE  A 252 ( 0.7A)
 1.27A 1upfD-5nqfB:
undetectable		 1upfD-5nqfB:
9.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_A_NCTA1208_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 8 TYR A 419
THR A 323
LEU A 377
MET A 374
 TYR  A 419 ( 1.3A)
THR  A 323 ( 0.8A)
LEU  A 377 ( 0.5A)
MET  A 374 ( 0.0A)
 1.20A 1uw6A-3gnrA:
undetectable
1uw6B-3gnrA:
undetectable		 1uw6A-3gnrA:
17.14
1uw6B-3gnrA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_D_NCTD1208_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 8 TYR A 419
THR A 323
LEU A 377
MET A 374
 TYR  A 419 ( 1.3A)
THR  A 323 ( 0.8A)
LEU  A 377 ( 0.5A)
MET  A 374 ( 0.0A)
 1.21A 1uw6D-3gnrA:
undetectable
1uw6E-3gnrA:
undetectable		 1uw6D-3gnrA:
17.14
1uw6E-3gnrA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_G_NCTG1206_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 8 TYR A 419
THR A 323
LEU A 377
MET A 374
 TYR  A 419 ( 1.3A)
THR  A 323 ( 0.8A)
LEU  A 377 ( 0.5A)
MET  A 374 ( 0.0A)
 1.22A 1uw6G-3gnrA:
undetectable
1uw6H-3gnrA:
undetectable		 1uw6G-3gnrA:
17.14
1uw6H-3gnrA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_P_NCTP1206_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 8 TYR A 419
THR A 323
LEU A 377
MET A 374
 TYR  A 419 ( 1.3A)
THR  A 323 ( 0.8A)
LEU  A 377 ( 0.5A)
MET  A 374 ( 0.0A)
 1.21A 1uw6P-3gnrA:
undetectable
1uw6Q-3gnrA:
undetectable		 1uw6P-3gnrA:
17.14
1uw6Q-3gnrA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_T_NCTT1208_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 8 LEU A 377
MET A 374
TYR A 419
THR A 323
 LEU  A 377 ( 0.5A)
MET  A 374 ( 0.0A)
TYR  A 419 ( 1.3A)
THR  A 323 ( 0.8A)
 1.22A 1uw6P-3gnrA:
undetectable
1uw6T-3gnrA:
undetectable		 1uw6P-3gnrA:
17.14
1uw6T-3gnrA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VHW_A_ADNA252_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.76A 1vhwA-4g41A:
24.5
1vhwD-4g41A:
24.6		 1vhwA-4g41A:
24.82
1vhwD-4g41A:
24.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VHW_C_ADNC252_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.77A 1vhwC-4g41A:
24.6
1vhwE-4g41A:
24.6		 1vhwC-4g41A:
24.82
1vhwE-4g41A:
24.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VHW_D_ADND252_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.76A 1vhwA-4g41A:
24.5
1vhwD-4g41A:
24.6		 1vhwA-4g41A:
24.82
1vhwD-4g41A:
24.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VHW_E_ADNE252_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.77A 1vhwC-4g41A:
24.6
1vhwE-4g41A:
24.6		 1vhwC-4g41A:
24.82
1vhwE-4g41A:
24.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WOP_A_FFOA2887_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		6 / 12 MET A  56
TYR A 113
VAL A 115
ASN A 117
TYR A 197
ARG A 233
 MET  A  56 (-0.0A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
 1.15A 1wopA-1wsvA:
50.1		 1wopA-1wsvA:
34.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WOP_A_FFOA2887_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		7 / 12 MET A  56
VAL A 115
ASN A 117
TYR A 371
TYR A 197
ARG A 233
TRP A 262
 MET  A  56 (-0.0A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 371 (-1.3A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
TRP  A 262 ( 0.5A)
 1.09A 1wopA-1wsvA:
50.1		 1wopA-1wsvA:
34.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WRL_C_TFPC208_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 4gow CALMODULIN
(Homo
sapiens) 		4 / 5 PHE D  92
LEU D 112
PHE D 141
MET D 145
 PHE  D  92 ( 1.3A)
LEU  D 112 ( 0.6A)
PHE  D 141 ( 1.3A)
MET  D 145 ( 0.0A)
 1.05A 1wrlC-4gowD:
11.4		 1wrlC-4gowD:
67.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WRL_F_TFPF209_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 4gow CALMODULIN
(Homo
sapiens) 		5 / 10 LEU D  18
GLU D 120
MET D 124
MET D 144
MET D 145
 LEU  D  18 ( 0.6A)
GLU  D 120 ( 0.6A)
MET  D 124 ( 0.0A)
MET  D 144 ( 0.0A)
MET  D 145 ( 0.0A)
 1.03A 1wrlE-4gowD:
11.4
1wrlF-4gowD:
11.3		 1wrlE-4gowD:
67.09
1wrlF-4gowD:
67.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WSV_A_THHA3001_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		12 / 12 MET A  56
THR A  87
LEU A  88
ILE A 103
VAL A 115
ASN A 117
PHE A 176
MET A 177
TYR A 197
ARG A 233
LEU A 242
TRP A 262
 MET  A  56 (-0.0A)
THR  A  87 ( 0.8A)
LEU  A  88 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
PHE  A 176 (-1.3A)
MET  A 177 (-0.0A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
LEU  A 242 (-0.6A)
TRP  A 262 ( 0.5A)
 0.02A 1wsvA-1wsvA:
66.6		 1wsvA-1wsvA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WSV_B_THHB4001_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		11 / 12 MET A  56
THR A  87
LEU A  88
ILE A 103
VAL A 115
ASN A 117
PHE A 176
MET A 177
TYR A 197
LEU A 242
TRP A 262
 MET  A  56 (-0.0A)
THR  A  87 ( 0.8A)
LEU  A  88 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
PHE  A 176 (-1.3A)
MET  A 177 (-0.0A)
TYR  A 197 (-1.3A)
LEU  A 242 (-0.6A)
TRP  A 262 ( 0.5A)
 0.19A 1wsvB-1wsvA:
62.3		 1wsvB-1wsvA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1X1A_A_SAMA4264_0
(CRTF-RELATED PROTEIN)		 1u1h 5-METHYLTETRAHYDROPT
EROYLTRIGLUTAMATE--H
OMOCYSTEINE
METHYLTRANSFERASE
(Arabidopsis
thaliana) 		5 / 12 ALA A 546
GLY A 438
GLY A 489
LEU A 735
ILE A 437
 None
MET  A 772 (-3.1A)
None
None
MET  A 772 (-4.6A)
 0.97A 1x1aA-1u1hA:
undetectable		 1x1aA-1u1hA:
19.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLX_A_CIOA101_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
HIS A 204
MET A 273
LEU A 319
ASN A 321
THR A 333
ILE A 336
MET A 337
SER A 368
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
HIS  A 204 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.54A 1xlxA-3sl5A:
51.0		 1xlxA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLX_B_CIOB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		10 / 12 TYR A 159
HIS A 160
HIS A 204
MET A 273
ILE A 336
MET A 337
PHE A 340
MET A 357
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
HIS  A 204 ( 1.0A)
MET  A 273 (-0.0A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.74A 1xlxB-3sl5A:
51.1		 1xlxB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLX_B_CIOB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
HIS A 204
MET A 273
THR A 333
ILE A 336
MET A 337
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
HIS  A 204 ( 1.0A)
MET  A 273 (-0.0A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.54A 1xlxB-3sl5A:
51.1		 1xlxB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XMU_A_ROFA101_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
ASP A 318
LEU A 319
PRO A 322
TYR A 329
TRP A 332
ILE A 336
PHE A 340
MET A 357
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.61A 1xmuA-3sl5A:
51.4		 1xmuA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XMU_A_ROFA101_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 5 MET A 273
ASN A 321
THR A 333
MET A 337
GLN A 369
 MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
THR  A 333 ( 0.8A)
MET  A 337 ( 0.0A)
GLN  A 369 (-0.6A)
 0.26A 1xmuA-3sl5A:
51.4		 1xmuA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XMU_B_ROFB102_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
PRO A 322
TYR A 329
TRP A 332
ILE A 336
PHE A 340
MET A 357
SER A 368
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
 0.44A 1xmuB-3sl5A:
51.1		 1xmuB-3sl5A:
84.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XMU_B_ROFB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 1d6s O-ACETYLSERINE
SULFHYDRYLASE
(Salmonella
enterica) 		4 / 5 ASN A  69
THR A  72
GLN A 142
PHE A 143
 MET  A 401 ( 3.8A)
MET  A 401 (-3.8A)
MET  A 401 (-3.0A)
None
 1.38A 1xmuB-1d6sA:
undetectable		 1xmuB-1d6sA:
20.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XMU_B_ROFB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 5 ASN A 321
THR A 333
MET A 337
GLN A 369
PHE A 372
 ASN  A 321 (-0.6A)
THR  A 333 ( 0.8A)
MET  A 337 ( 0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.51A 1xmuB-3sl5A:
51.1		 1xmuB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOM_A_CIOA603_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		6 / 12 TYR A 159
ASP A 201
ILE A 336
MET A 337
PHE A 340
MET A 357
 TYR  A 159 (-1.3A)
ASP  A 201 ( 0.5A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
 1.47A 1xomA-3sl5A:
53.0		 1xomA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOM_A_CIOA603_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
ILE A 336
MET A 337
PHE A 340
MET A 357
SER A 368
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.57A 1xomA-3sl5A:
53.0		 1xomA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOM_B_CIOB601_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
THR A 333
ILE A 336
MET A 337
PHE A 340
MET A 357
SER A 368
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.59A 1xomB-3sl5A:
52.8		 1xomB-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOQ_A_ROFA502_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
PRO A 322
TYR A 329
THR A 333
ILE A 336
MET A 357
SER A 368
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
 0.54A 1xoqA-3sl5A:
53.5		 1xoqA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOQ_A_ROFA502_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
PRO A 322
TYR A 329
THR A 333
ILE A 336
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.52A 1xoqA-3sl5A:
53.5		 1xoqA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOQ_B_ROFB501_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
ASP A 318
LEU A 319
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
MET A 357
SER A 368
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
 0.49A 1xoqB-3sl5A:
53.4		 1xoqB-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOQ_B_ROFB501_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		3 / 3 MET A 273
ASN A 321
GLN A 369
 MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
GLN  A 369 (-0.6A)
 0.31A 1xoqB-3sl5A:
53.4		 1xoqB-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOS_A_VIAA1_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
MET A 337
PHE A 340
MET A 357
GLN A 369
PHE A 372
ILE A 376
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
ILE  A 376 (-0.6A)
 0.48A 1xosA-3sl5A:
51.3		 1xosA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOS_A_VIAA1_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		10 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
MET A 337
PHE A 340
SER A 355
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
SER  A 355 ( 0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 1.02A 1xosA-3sl5A:
51.3		 1xosA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOT_A_VDNA101_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
ILE A 336
MET A 337
SER A 355
MET A 357
SER A 368
GLN A 369
PHE A 372
ILE A 376
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 355 ( 0.0A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
ILE  A 376 (-0.6A)
 0.74A 1xotA-3sl5A:
50.9		 1xotA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOT_B_VDNB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
ASN A 321
ILE A 336
MET A 337
SER A 355
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 355 ( 0.0A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.59A 1xotB-3sl5A:
50.9		 1xotB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOT_B_VDNB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
ASN A 321
ILE A 336
MET A 337
SER A 355
MET A 357
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 355 ( 0.0A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.73A 1xotB-3sl5A:
50.9		 1xotB-3sl5A:
84.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z35_A_2FAA300_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.69A 1z35A-4g41A:
23.2		 1z35A-4g41A:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z37_A_ADNA300_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 9 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.80A 1z37A-4g41A:
23.1		 1z37A-4g41A:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z37_A_ADNA300_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 9 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.81A 1z37A-4g41A:
23.1		 1z37A-4g41A:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_A_TEPA1433_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 11 TYR A 156
PHE A 184
GLY A 267
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.39A 2a3aA-5gprA:
12.4		 2a3aA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_A_TEPA1433_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		8 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
GLU A 308
MET A 381
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TRP  A 532 ( 0.5A)
 0.65A 2a3aA-5gprA:
12.4		 2a3aA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_B_TEPB2433_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		8 / 9 PHE A 184
GLY A 267
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.47A 2a3aB-5gprA:
43.1		 2a3aB-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1435_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		9 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
GLU A 308
MET A 381
TYR A 383
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.78A 2a3bA-5gprA:
43.0		 2a3bA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1435_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.57A 2a3bA-5gprA:
43.0		 2a3bA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2435_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		9 / 10 PHE A 184
GLY A 267
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.67A 2a3bB-5gprA:
43.1		 2a3bB-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_A_PNXA1434_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		9 / 12 TYR A 156
TRP A 160
PHE A 184
GLY A 267
ASP A 306
GLU A 308
MET A 381
TYR A 383
TRP A 532
 TYR  A 156 ( 1.3A)
TRP  A 160 ( 0.5A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.72A 2a3cA-5gprA:
12.4		 2a3cA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_A_PNXA1434_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 12 TYR A 156
TRP A 160
PHE A 184
GLY A 267
ASP A 306
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TYR  A 156 ( 1.3A)
TRP  A 160 ( 0.5A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.44A 2a3cA-5gprA:
12.4		 2a3cA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_B_PNXB2433_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		11 / 12 TRP A 160
PHE A 184
GLY A 267
THR A 269
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TRP  A 160 ( 0.5A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
THR  A 269 ( 0.8A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.71A 2a3cB-5gprA:
43.1		 2a3cB-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AOI_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 6fd2 PUTATIVE APRAMYCIN
BIOSYNTHETIC
OXIDOREDUCTASE 4
(Streptoalloteich
us
tenebrarius) 		4 / 5 GLY B 221
PRO B 252
VAL B 253
ILE B 224
 None
None
MET  B 503 ( 4.9A)
None
 1.00A 2aoiA-6fd2B:
undetectable		 2aoiA-6fd2B:
22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BJF_A_DXCA330_0
(CHOLOYLGLYCINE
HYDROLASE)		 4ikn AP-3 COMPLEX SUBUNIT
MU-1
(Rattus
norvegicus) 		5 / 12 MET A 314
PHE A 282
ASN A 372
THR A 418
LEU A 373
 MET  A 314 ( 0.0A)
PHE  A 282 ( 1.3A)
ASN  A 372 ( 0.6A)
THR  A 418 ( 0.8A)
LEU  A 373 ( 0.5A)
 1.19A 2bjfA-4iknA:
undetectable		 2bjfA-4iknA:
21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIK_J_CHDJ60_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 LEU A 379
PHE A 407
ARG A 249
MET A 343
 LEU  A 379 ( 0.6A)
PHE  A 407 ( 1.3A)
ARG  A 249 ( 0.6A)
MET  A 343 ( 0.0A)
 1.01A 2eikA-3o96A:
0.5
2eikJ-3o96A:
undetectable		 2eikA-3o96A:
19.89
2eikJ-3o96A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FB2_A_SAMA501_0
(MOLYBDENUM COFACTOR
BIOSYNTHESIS PROTEIN
A)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		4 / 8 CYH A 132
GLU A 180
SER A 233
VAL A 280
 SF4  A 502 ( 2.2A)
MET  A 501 (-4.0A)
MET  A 501 ( 2.6A)
5AD  A 503 (-4.8A)
 0.69A 2fb2A-5hr6A:
12.2		 2fb2A-5hr6A:
23.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQY_A_ADNA400_1
(MEMBRANE LIPOPROTEIN
TMPC)		 4ki5 MURINE MONOCLONAL
G99 FAB HEAVY CHAIN
(Mus
musculus) 		5 / 12 ASP E  90
PHE E  64
MET E  81
PHE E  70
GLY E  66
 ASP  E  90 ( 0.6A)
PHE  E  64 ( 1.3A)
MET  E  81 ( 0.0A)
PHE  E  70 ( 1.3A)
GLY  E  66 ( 0.0A)
 1.27A 2fqyA-4ki5E:
undetectable		 2fqyA-4ki5E:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_A_MIXA539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		7 / 12 LEU A 156
VAL A 164
ALA A 177
ASP A 274
LYS A 276
ASN A 279
MET A 281
 LEU  A 156 ( 0.6A)
VAL  A 164 ( 0.6A)
ALA  A 177 ( 0.0A)
ASP  A 274 ( 0.5A)
LYS  A 276 ( 0.0A)
ASN  A 279 ( 0.6A)
MET  A 281 ( 0.0A)
 0.83A 2fumA-3o96A:
24.2		 2fumA-3o96A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_C_MIXC2539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		6 / 12 LEU A 156
GLY A 157
VAL A 164
ALA A 177
MET A 227
TYR A 229
 LEU  A 156 ( 0.6A)
GLY  A 157 ( 0.0A)
VAL  A 164 ( 0.6A)
ALA  A 177 ( 0.0A)
MET  A 227 ( 0.0A)
TYR  A 229 ( 1.3A)
 0.71A 2fumC-3o96A:
24.2		 2fumC-3o96A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_D_MIXD3539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		7 / 12 LEU A 156
VAL A 164
ALA A 177
MET A 227
LYS A 276
ASN A 279
MET A 281
 LEU  A 156 ( 0.6A)
VAL  A 164 ( 0.6A)
ALA  A 177 ( 0.0A)
MET  A 227 ( 0.0A)
LYS  A 276 ( 0.0A)
ASN  A 279 ( 0.6A)
MET  A 281 ( 0.0A)
 0.92A 2fumD-3o96A:
24.0		 2fumD-3o96A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2GEH_A_NHYA300_1
(CARBONIC ANHYDRASE 2)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 HIS A 237
HIS A 235
HIS A 255
LEU A 202
 MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MET  A 600 (-3.7A)
 0.91A 2gehA-2qs8A:
undetectable		 2gehA-2qs8A:
24.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_A_SCKA901_1
(ACETYLCHOLINESTERASE)		 3gxa OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 8 ASP A  80
TYR A 216
TYR A 103
HIS A 100
 None
None
MET  A 296 (-3.7A)
MET  A 296 (-3.6A)
 1.40A 2ha2A-3gxaA:
undetectable		 2ha2A-3gxaA:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_A_SCKA901_1
(ACETYLCHOLINESTERASE)		 3ir1 OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 8 ASP A  80
TYR A 216
TYR A 103
HIS A 100
 None
None
MET  A 600 (-3.6A)
MET  A 600 (-3.6A)
 1.42A 2ha2A-3ir1A:
undetectable		 2ha2A-3ir1A:
18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_A_SCKA901_1
(ACETYLCHOLINESTERASE)		 3tqw METHIONINE-BINDING
PROTEIN
(Coxiella
burnetii) 		4 / 8 ASP A  37
TYR A 172
TYR A  60
HIS A  57
 None
None
MET  A 238 (-3.7A)
MET  A 238 (-3.5A)
 1.48A 2ha2A-3tqwA:
undetectable		 2ha2A-3tqwA:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_A_SCKA901_1
(ACETYLCHOLINESTERASE)		 4ib2 PUTATIVE LIPOPROTEIN
([Ruminococcus]
gnavus) 		4 / 8 ASP A  73
TYR A 208
TYR A  96
HIS A  93
 None
CL  A 301 (-4.6A)
MET  A 305 (-3.7A)
MET  A 305 (-3.5A)
 1.39A 2ha2A-4ib2A:
undetectable		 2ha2A-4ib2A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_A_SCKA901_1
(ACETYLCHOLINESTERASE)		 4yah D-METHIONINE-BINDING
LIPOPROTEIN METQ
(Escherichia
coli) 		4 / 8 ASP X  68
TYR X 205
TYR X  91
HIS X  88
 None
None
MET  X 301 (-2.8A)
MET  X 301 (-3.4A)
 1.36A 2ha2A-4yahX:
undetectable		 2ha2A-4yahX:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_B_SCKB951_1
(ACETYLCHOLINESTERASE)		 3gxa OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 8 ASP A  80
TYR A 216
TYR A 103
HIS A 100
 None
None
MET  A 296 (-3.7A)
MET  A 296 (-3.6A)
 1.36A 2ha2B-3gxaA:
undetectable		 2ha2B-3gxaA:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_B_SCKB951_1
(ACETYLCHOLINESTERASE)		 3ir1 OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 8 ASP A  80
TYR A 216
TYR A 103
HIS A 100
 None
None
MET  A 600 (-3.6A)
MET  A 600 (-3.6A)
 1.38A 2ha2B-3ir1A:
undetectable		 2ha2B-3ir1A:
18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_B_SCKB951_1
(ACETYLCHOLINESTERASE)		 3tqw METHIONINE-BINDING
PROTEIN
(Coxiella
burnetii) 		4 / 8 ASP A  37
TYR A 172
TYR A  60
HIS A  57
 None
None
MET  A 238 (-3.7A)
MET  A 238 (-3.5A)
 1.47A 2ha2B-3tqwA:
undetectable		 2ha2B-3tqwA:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_B_SCKB951_1
(ACETYLCHOLINESTERASE)		 4ib2 PUTATIVE LIPOPROTEIN
([Ruminococcus]
gnavus) 		4 / 8 ASP A  73
TYR A 208
TYR A  96
HIS A  93
 None
CL  A 301 (-4.6A)
MET  A 305 (-3.7A)
MET  A 305 (-3.5A)
 1.35A 2ha2B-4ib2A:
undetectable		 2ha2B-4ib2A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA2_B_SCKB951_1
(ACETYLCHOLINESTERASE)		 4yah D-METHIONINE-BINDING
LIPOPROTEIN METQ
(Escherichia
coli) 		4 / 8 ASP X  68
TYR X 205
TYR X  91
HIS X  88
 None
None
MET  X 301 (-2.8A)
MET  X 301 (-3.4A)
 1.32A 2ha2B-4yahX:
undetectable		 2ha2B-4yahX:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA4_A_ACHA546_0
(ACETYLCHOLINESTERASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		4 / 8 TYR A 265
GLU A 187
HIS A 153
GLY A 152
 MET  A1298 ( 4.7A)
MN  A 296 ( 2.6A)
MN  A 296 ( 3.3A)
None
 0.83A 2ha4A-1wkmA:
undetectable		 2ha4A-1wkmA:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA4_B_ACHB603_0
(ACETYLCHOLINESTERASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		4 / 7 TYR A 265
GLU A 187
HIS A 153
GLY A 152
 MET  A1298 ( 4.7A)
MN  A 296 ( 2.6A)
MN  A 296 ( 3.3A)
None
 0.81A 2ha4B-1wkmA:
undetectable		 2ha4B-1wkmA:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IJ7_A_TPFA2472_1
(CYTOCHROME P450 121)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 11 THR A 135
ASN A  18
MET A  17
THR A 123
ALA A 126
 THR  A 135 ( 0.8A)
ASN  A  18 ( 0.6A)
MET  A  17 ( 0.0A)
THR  A 123 ( 0.8A)
ALA  A 126 ( 0.0A)
 1.27A 2ij7A-2ogsA:
0.0		 2ij7A-2ogsA:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IJ7_B_TPFB2470_1
(CYTOCHROME P450 121)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 9 THR A 135
ASN A  18
MET A  17
THR A 123
ALA A 126
 THR  A 135 ( 0.8A)
ASN  A  18 ( 0.6A)
MET  A  17 ( 0.0A)
THR  A 123 ( 0.8A)
ALA  A 126 ( 0.0A)
 1.29A 2ij7B-2ogsA:
0.0		 2ij7B-2ogsA:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IT4_A_PPFA500_1
(CARBONIC ANHYDRASE 1)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 HIS A 237
HIS A 235
HIS A 255
LEU A 202
 MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MET  A 600 (-3.7A)
 0.85A 2it4A-2qs8A:
undetectable		 2it4A-2qs8A:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_A_RALA600_1
(ESTROGEN RECEPTOR)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		5 / 12 THR A 306
ALA A 309
LEU A  67
LEU A  74
MET A 430
 THR  A 306 ( 0.8A)
ALA  A 309 ( 0.0A)
LEU  A  67 ( 0.5A)
LEU  A  74 ( 0.6A)
MET  A 430 ( 0.0A)
 1.11A 2jfaA-4mwtA:
undetectable		 2jfaA-4mwtA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2KUH_A_HLTA150_1
(CALMODULIN)		 5svd NUCLEOLAR PROTEIN 9
(Saccharomyces
cerevisiae) 		4 / 6 LEU A 517
MET A 509
LEU A 461
MET A 520
 LEU  A 517 ( 0.5A)
MET  A 509 ( 0.0A)
LEU  A 461 ( 0.6A)
MET  A 520 ( 0.0A)
 1.11A 2kuhA-5svdA:
undetectable		 2kuhA-5svdA:
8.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NMZ_B_ROCB401_2
(PROTEASE)		 5exk LIPOYL SYNTHASE
(Mycobacterium
tuberculosis) 		3 / 3 ARG A  83
VAL A  54
THR A 121
 None
None
MET  A 404 (-3.7A)
 0.83A 2nmzA-5exkA:
undetectable		 2nmzA-5exkA:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OXT_B_SAMB300_1
(NUCLEOSIDE-2'-O-METH
YLTRANSFERASE)		 1u1h 5-METHYLTETRAHYDROPT
EROYLTRIGLUTAMATE--H
OMOCYSTEINE
METHYLTRANSFERASE
(Arabidopsis
thaliana) 		4 / 5 SER A 439
GLY A 734
ASP A 666
ASP A 605
 MET  A 772 (-2.8A)
MET  A 772 (-3.2A)
None
MET  A 772 (-3.8A)
 1.09A 2oxtB-1u1hA:
undetectable		 2oxtB-1u1hA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OZ7_A_CA4A1_2
(ANDROGEN RECEPTOR)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		4 / 6 LEU A 469
MET A 299
MET A 296
LEU A 302
 LEU  A 469 (-0.6A)
MET  A 299 ( 0.0A)
MET  A 296 ( 0.0A)
LEU  A 302 ( 0.6A)
 1.45A 2oz7A-4zkeA:
undetectable		 2oz7A-4zkeA:
18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PIW_A_T3A933_1
(ANDROGEN RECEPTOR)		 4ib2 PUTATIVE LIPOPROTEIN
([Ruminococcus]
gnavus) 		5 / 10 ILE A 266
GLY A 206
ASN A 205
PHE A 119
GLU A 224
 None
None
MET  A 305 (-3.8A)
None
None
 1.28A 2piwA-4ib2A:
undetectable		 2piwA-4ib2A:
21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PO5_A_CHDA502_0
(FERROCHELATASE,
MITOCHONDRIAL)		 5x7y LIPOCALIN-CAN F 6
ALLERGEN
(Canis
lupus) 		4 / 8 MET A  59
LEU A  72
LEU A 119
GLY A  38
 MET  A  59 ( 0.0A)
LEU  A  72 ( 0.6A)
LEU  A 119 ( 0.6A)
GLY  A  38 ( 0.0A)
 0.82A 2po5A-5x7yA:
undetectable		 2po5A-5x7yA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QD3_B_CHDB504_0
(FERROCHELATASE)		 4yzr POLYKETIDE
BIOSYNTHESIS
CYTOCHROME P450 PKSS
(Bacillus
subtilis) 		4 / 6 ILE A  62
ARG A  64
SER A 319
MET A 290
 ILE  A  62 ( 0.6A)
ARG  A  64 (-0.6A)
SER  A 319 ( 0.0A)
MET  A 290 ( 0.0A)
 1.12A 2qd3B-4yzrA:
undetectable		 2qd3B-4yzrA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2RHM_D_BEZD194_0
(PUTATIVE KINASE)		 5exk LIPOYL SYNTHASE
(Mycobacterium
tuberculosis) 		4 / 5 PRO A 193
ILE A 191
ARG A 192
ASP A  86
 None
None
MET  A 404 ( 2.9A)
IMD  A 405 (-3.9A)
 1.50A 2rhmD-5exkA:
1.5		 2rhmD-5exkA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		 1p1m HYPOTHETICAL PROTEIN
TM0936
(Thermotoga
maritima) 		5 / 11 LEU A  62
ALA A  58
THR A  56
ARG A 148
GLU A 151
 None
None
None
MET  A5001 (-3.9A)
None
 1.24A 2v0mD-1p1mA:
0.0		 2v0mD-1p1mA:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VJ1_A_BEZA1303_0
(SARS CORONAVIRUS
MAIN PROTEINASE)		 1joi AZURIN
(Pseudomonas
fluorescens) 		3 / 3 HIS A 117
MET A 121
MET A  44
 HIS  A 117 (-0.9A)
MET  A 121 (-0.0A)
MET  A  44 ( 0.0A)
 1.44A 2vj1A-1joiA:
0.0		 2vj1A-1joiA:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEK_B_DIFB1374_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)		 1xs5 MEMBRANE LIPOPROTEIN
TPN32
(Treponema
pallidum) 		4 / 6 TYR A  44
ILE A 110
ASN A 175
LEU A  89
 MET  A 301 (-3.7A)
None
MET  A 301 (-3.8A)
None
 1.35A 2wekB-1xs5A:
undetectable		 2wekB-1xs5A:
19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEY_A_EV1A1771_1
(CAMP AND
CAMP-INHIBITED CGMP
3', 5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		8 / 12 TYR A 159
HIS A 160
LEU A 319
ILE A 336
GLU A 339
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
LEU  A 319 ( 0.6A)
ILE  A 336 ( 0.4A)
GLU  A 339 ( 0.5A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 1.01A 2weyA-3sl5A:
37.9		 2weyA-3sl5A:
27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEY_B_EV1B1771_1
(CAMP AND
CAMP-INHIBITED CGMP
3', 5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		4 / 8 ILE A 336
MET A 357
GLN A 369
PHE A 372
 ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.86A 2weyB-3sl5A:
37.4		 2weyB-3sl5A:
27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WUZ_A_TPFA1460_1
(LANOSTEROL
14-ALPHA-DEMETHYLASE
, PUTATIVE)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		5 / 10 ALA C 341
ALA C 289
LEU C 250
MET C 384
VAL C 248
 ALA  C 341 ( 0.0A)
ALA  C 289 ( 0.0A)
LEU  C 250 ( 0.6A)
MET  C 384 ( 0.0A)
VAL  C 248 ( 0.6A)
 1.09A 2wuzA-3ghgC:
undetectable		 2wuzA-3ghgC:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WUZ_B_TPFB1460_1
(LANOSTEROL
14-ALPHA-DEMETHYLASE
, PUTATIVE)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		5 / 10 ALA C 341
ALA C 289
LEU C 250
MET C 384
VAL C 248
 ALA  C 341 ( 0.0A)
ALA  C 289 ( 0.0A)
LEU  C 250 ( 0.6A)
MET  C 384 ( 0.0A)
VAL  C 248 ( 0.6A)
 1.07A 2wuzB-3ghgC:
undetectable		 2wuzB-3ghgC:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X0P_A_ADNA1607_1
(ALCALIGIN
BIOSYNTHESIS PROTEIN)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		4 / 8 GLY A 227
ASN A 410
MET A 409
GLU A 221
 GLY  A 227 ( 0.0A)
ASN  A 410 ( 0.6A)
MET  A 409 ( 0.0A)
GLU  A 221 (-0.6A)
 0.80A 2x0pA-3ulkA:
0.5		 2x0pA-3ulkA:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X0P_A_ADNA1607_1
(ALCALIGIN
BIOSYNTHESIS PROTEIN)		 5l5n PLEXIN-A4
(Mus
musculus) 		5 / 8 GLY A  65
HIS A  52
ILE A  62
MET A 496
ALA A 128
 GLY  A  65 ( 0.0A)
HIS  A  52 ( 1.0A)
ILE  A  62 ( 0.6A)
MET  A 496 ( 0.0A)
ALA  A 128 ( 0.0A)
 1.10A 2x0pA-5l5nA:
undetectable		 2x0pA-5l5nA:
17.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2X1L_A_ADNA601_1
(METHIONYL-TRNA
SYNTHETASE)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		10 / 11 ALA A  10
ALA A  12
GLY A  21
HIS A  22
GLU A  25
GLY A 263
ASP A 265
ILE A 266
HIS A 292
TRP A 294
 MET  A 600 ( 3.9A)
MET  A 600 (-3.8A)
None
None
None
None
None
MET  A 600 (-3.9A)
None
None
 0.71A 2x1lA-2x1mA:
57.8		 2x1lA-2x1mA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2X1L_A_ADNA601_1
(METHIONYL-TRNA
SYNTHETASE)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		7 / 11 HIS A 256
GLY A 258
HIS A 259
GLY A 516
ASP A 518
ILE A 519
HIS A 545
 None
None
None
None
None
MET  A 807 ( 4.4A)
None
 0.40A 2x1lA-5nfhA:
45.1		 2x1lA-5nfhA:
42.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X1L_A_ADNA601_1
(METHIONYL-TRNA
SYNTHETASE)		 5urb METHIONINE--TRNA
LIGASE
(Acinetobacter
baumannii) 		5 / 11 ALA A   9
GLY A  20
GLY A 292
ASP A 294
ILE A 295
 MET  A 603 ( 4.0A)
None
None
None
MET  A 603 (-4.3A)
 0.62A 2x1lA-5urbA:
37.9		 2x1lA-5urbA:
28.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2X1L_B_ADNB601_1
(METHIONYL-TRNA
SYNTHETASE)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		10 / 12 ALA A  10
ALA A  12
GLY A  21
HIS A  22
GLU A  25
GLY A 263
ASP A 265
ILE A 266
HIS A 292
LEU A 295
 MET  A 600 ( 3.9A)
MET  A 600 (-3.8A)
None
None
None
None
None
MET  A 600 (-3.9A)
None
None
 0.57A 2x1lB-2x1mA:
55.4		 2x1lB-2x1mA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2X1L_B_ADNB601_1
(METHIONYL-TRNA
SYNTHETASE)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		10 / 12 ALA A  10
ALA A  12
GLY A  21
HIS A  22
GLU A  25
GLY A 263
ASP A 265
ILE A 266
HIS A 292
TRP A 294
 MET  A 600 ( 3.9A)
MET  A 600 (-3.8A)
None
None
None
None
None
MET  A 600 (-3.9A)
None
None
 0.73A 2x1lB-2x1mA:
55.4		 2x1lB-2x1mA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2X1L_B_ADNB601_1
(METHIONYL-TRNA
SYNTHETASE)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		7 / 12 HIS A 256
GLY A 258
HIS A 259
GLY A 516
ASP A 518
ILE A 519
HIS A 545
 None
None
None
None
None
MET  A 807 ( 4.4A)
None
 0.44A 2x1lB-5nfhA:
43.0		 2x1lB-5nfhA:
42.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X1L_B_ADNB601_1
(METHIONYL-TRNA
SYNTHETASE)		 5urb METHIONINE--TRNA
LIGASE
(Acinetobacter
baumannii) 		6 / 12 ALA A   9
GLY A  20
GLY A 292
ASP A 294
ILE A 295
LEU A 324
 MET  A 603 ( 4.0A)
None
None
None
MET  A 603 (-4.3A)
None
 0.67A 2x1lB-5urbA:
40.5		 2x1lB-5urbA:
28.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2X1L_C_ADNC601_1
(METHIONYL-TRNA
SYNTHETASE)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		10 / 11 ALA A  10
ALA A  12
GLY A  21
HIS A  22
GLU A  25
GLY A 263
ASP A 265
ILE A 266
HIS A 292
TRP A 294
 MET  A 600 ( 3.9A)
MET  A 600 (-3.8A)
None
None
None
None
None
MET  A 600 (-3.9A)
None
None
 0.71A 2x1lC-2x1mA:
54.7		 2x1lC-2x1mA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2X1L_C_ADNC601_1
(METHIONYL-TRNA
SYNTHETASE)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		7 / 11 HIS A 256
GLY A 258
HIS A 259
GLY A 516
ASP A 518
ILE A 519
HIS A 545
 None
None
None
None
None
MET  A 807 ( 4.4A)
None
 0.44A 2x1lC-5nfhA:
43.0		 2x1lC-5nfhA:
42.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X1L_C_ADNC601_1
(METHIONYL-TRNA
SYNTHETASE)		 5urb METHIONINE--TRNA
LIGASE
(Acinetobacter
baumannii) 		5 / 11 ALA A   9
GLY A  20
GLY A 292
ASP A 294
ILE A 295
 MET  A 603 ( 4.0A)
None
None
None
MET  A 603 (-4.3A)
 0.65A 2x1lC-5urbA:
40.4		 2x1lC-5urbA:
28.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XKW_B_P1BB1475_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 5e37 EF-HAND
DOMAIN-CONTAINING
THIOREDOXIN
(Chlamydomonas
reinhardtii) 		5 / 12 GLU A 216
ALA A 116
LEU A 178
ILE A 164
MET A 153
 GLU  A 216 ( 0.5A)
ALA  A 116 ( 0.0A)
LEU  A 178 ( 0.6A)
ILE  A 164 ( 0.7A)
MET  A 153 ( 0.0A)
 1.31A 2xkwB-5e37A:
undetectable		 2xkwB-5e37A:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6R_A_CTCA1385_0
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 10 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.21A 2y6rA-5gprA:
undetectable		 2y6rA-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YJA_B_ESTB1550_1
(ESTROGEN RECEPTOR)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 12 ALA A 317
LEU A 175
LEU A 176
MET A 122
ILE A 125
 ALA  A 317 ( 0.0A)
LEU  A 175 ( 0.6A)
LEU  A 176 ( 0.6A)
MET  A 122 ( 0.0A)
ILE  A 125 ( 0.6A)
 1.14A 2yjaB-3sl5A:
undetectable		 2yjaB-3sl5A:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YVL_B_SAMB602_1
(HYPOTHETICAL PROTEIN)		 4qhq LIPOPROTEIN
(Burkholderia
cenocepacia) 		3 / 3 GLU A  43
ASP A  41
TYR A 109
 PEG  A 302 (-3.2A)
MET  A 301 ( 4.7A)
None
 0.79A 2yvlB-4qhqA:
undetectable		 2yvlB-4qhqA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZVJ_A_SAMA301_0
(CATECHOL
O-METHYLTRANSFERASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 ASN A 293
VAL A 294
MET A 224
ASN A 225
HIS A 220
 ASN  A 293 ( 0.6A)
VAL  A 294 ( 0.6A)
MET  A 224 ( 0.0A)
ASN  A 225 ( 0.6A)
HIS  A 220 ( 1.0A)
 1.49A 2zvjA-5nqfA:
undetectable		 2zvjA-5nqfA:
19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZXW_W_CHDW1060_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 LEU A 379
PHE A 407
ARG A 249
MET A 343
 LEU  A 379 ( 0.6A)
PHE  A 407 ( 1.3A)
ARG  A 249 ( 0.6A)
MET  A 343 ( 0.0A)
 1.01A 2zxwN-3o96A:
undetectable
2zxwW-3o96A:
undetectable		 2zxwN-3o96A:
19.89
2zxwW-3o96A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A50_B_VD3B2001_1
(VITAMIN D
HYDROXYLASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 THR A 198
MET A  56
ILE A  63
LEU A 105
ILE A 103
 THR  A 198 ( 0.8A)
MET  A  56 ( 0.0A)
ILE  A  63 ( 0.7A)
LEU  A 105 (-0.5A)
ILE  A 103 ( 0.7A)
 1.29A 3a50B-3ulkA:
undetectable		 3a50B-3ulkA:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A50_C_VD3C2001_1
(VITAMIN D
HYDROXYLASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 THR A 198
MET A  56
ILE A  63
LEU A 105
ILE A 103
 THR  A 198 ( 0.8A)
MET  A  56 ( 0.0A)
ILE  A  63 ( 0.7A)
LEU  A 105 (-0.5A)
ILE  A 103 ( 0.7A)
 1.31A 3a50C-3ulkA:
undetectable		 3a50C-3ulkA:
22.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_A_C2FA401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		7 / 12 MET A  56
ASP A 101
ILE A 103
VAL A 115
ASN A 117
TYR A 197
ARG A 233
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
 0.28A 3a8iA-1wsvA:
46.8		 3a8iA-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_A_C2FA401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		6 / 12 MET A  56
ASP A 101
TYR A 113
VAL A 115
ASN A 117
ARG A 233
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
ARG  A 233 (-0.6A)
 1.11A 3a8iA-1wsvA:
46.8		 3a8iA-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_B_C2FB401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		8 / 12 MET A  56
ASP A 101
ILE A 103
VAL A 115
ASN A 117
TYR A 197
ARG A 233
TRP A 262
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
TRP  A 262 ( 0.5A)
 0.32A 3a8iB-1wsvA:
46.2		 3a8iB-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_B_C2FB401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		6 / 12 MET A  56
ASP A 101
TYR A 113
VAL A 115
ASN A 117
ARG A 233
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
ARG  A 233 (-0.6A)
 1.12A 3a8iB-1wsvA:
46.2		 3a8iB-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_C_C2FC401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		7 / 12 MET A  56
ILE A 103
VAL A 115
ASN A 117
TYR A 197
ARG A 233
TRP A 262
 MET  A  56 (-0.0A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
TRP  A 262 ( 0.5A)
 0.44A 3a8iC-1wsvA:
46.4		 3a8iC-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_C_C2FC401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		6 / 12 MET A  56
TYR A 113
VAL A 115
ASN A 117
TYR A 197
ARG A 233
 MET  A  56 (-0.0A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
 1.16A 3a8iC-1wsvA:
46.4		 3a8iC-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_D_C2FD401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		8 / 12 MET A  56
ASP A 101
ILE A 103
VAL A 115
ASN A 117
TYR A 197
ARG A 233
TRP A 262
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
TRP  A 262 ( 0.5A)
 0.39A 3a8iD-1wsvA:
46.3		 3a8iD-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_D_C2FD401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		7 / 12 MET A  56
ASP A 101
TYR A 113
VAL A 115
ASN A 117
TYR A 197
ARG A 233
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
 1.12A 3a8iD-1wsvA:
46.3		 3a8iD-1wsvA:
33.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ADS_A_IMNA2_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1
(Homo
sapiens) 		4 / 6 ILE A 301
ILE A 244
LEU A 288
MET A 281
 ILE  A 301 ( 0.7A)
ILE  A 244 ( 0.7A)
LEU  A 288 ( 0.6A)
MET  A 281 ( 0.0A)
 1.01A 3adsA-2qv2A:
undetectable		 3adsA-2qv2A:
23.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG4_W_CHDW1059_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 LEU A 379
PHE A 407
ARG A 249
MET A 343
 LEU  A 379 ( 0.6A)
PHE  A 407 ( 1.3A)
ARG  A 249 ( 0.6A)
MET  A 343 ( 0.0A)
 1.04A 3ag4N-3o96A:
1.0
3ag4W-3o96A:
undetectable		 3ag4N-3o96A:
19.89
3ag4W-3o96A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CLD_B_GW6B2_2
(GLUCOCORTICOID
RECEPTOR)		 6ezy -
(-) 		4 / 8 LEU A 110
ALA A 140
LEU A 143
MET A 184
 LEU  A 110 ( 0.6A)
ALA  A 140 ( 0.0A)
LEU  A 143 ( 0.5A)
MET  A 184 ( 0.0A)
 0.82A 3cldB-6ezyA:
undetectable		 3cldB-6ezyA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CR5_X_PNTX94_0
(PROTEIN S100-B)		 5exk LIPOYL SYNTHASE
(Mycobacterium
tuberculosis) 		3 / 3 PHE A 195
CYH A  85
PHE A  87
 MET  A 404 ( 4.4A)
SF4  A 402 ( 2.3A)
SF4  A 402 ( 4.6A)
 1.08A 3cr5X-5exkA:
undetectable		 3cr5X-5exkA:
14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DH0_A_SAMA220_1
(SAM DEPENDENT
METHYLTRANSFERASE)		 5c6d UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 7
E3 UBIQUITIN-PROTEIN
LIGASE UHRF1
(Homo
sapiens;
Homo
sapiens) 		4 / 8 LYS C 657
ASP A 764
MET A 761
GLU A 744
 LYS  C 657 ( 0.0A)
ASP  A 764 ( 0.6A)
MET  A 761 ( 0.0A)
GLU  A 744 ( 0.6A)
 1.42A 3dh0A-5c6dC:
undetectable		 3dh0A-5c6dC:
8.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ELZ_A_CHDA150_0
(ILEAL BILE
ACID-BINDING PROTEIN)		 2qj6 TOXIN A
(Clostridioides
difficile) 		5 / 12 PHE A 315
MET A 303
THR A 290
VAL A 289
ILE A 317
 PHE  A 315 ( 1.3A)
MET  A 303 ( 0.0A)
THR  A 290 ( 0.8A)
VAL  A 289 ( 0.6A)
ILE  A 317 ( 0.6A)
 1.40A 3elzA-2qj6A:
undetectable		 3elzA-2qj6A:
18.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_A_ROFA901_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		10 / 12 TYR A 159
HIS A 160
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
MET A 357
SER A 368
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
 0.52A 3g4lA-3sl5A:
53.4		 3g4lA-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_A_ROFA901_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.44A 3g4lA-3sl5A:
53.4		 3g4lA-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_B_ROFB902_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
PRO A 322
TRP A 332
THR A 333
ILE A 336
MET A 337
MET A 357
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
MET  A 357 (-0.0A)
PHE  A 372 (-1.3A)
 0.53A 3g4lB-3sl5A:
52.8		 3g4lB-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_C_ROFC903_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
MET A 357
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
 0.46A 3g4lC-3sl5A:
53.0		 3g4lC-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_D_ROFD904_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
PRO A 322
TRP A 332
THR A 333
ILE A 336
MET A 337
SER A 368
GLN A 369
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
 0.33A 3g4lD-3sl5A:
52.9		 3g4lD-3sl5A:
98.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G6M_A_CFFA1_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		11 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.49A 3g6mA-5gprA:
7.2		 3g6mA-5gprA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G6M_A_CFFA427_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		4 / 5 TRP A 268
MET A 381
ASP A 384
TRP A 389
 TRP  A 268 ( 0.5A)
MET  A 381 ( 0.0A)
ASP  A 384 ( 0.5A)
TRP  A 389 (-0.5A)
 0.75A 3g6mA-5gprA:
7.2		 3g6mA-5gprA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3H52_D_486D2_1
(GLUCOCORTICOID
RECEPTOR)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 12 GLY A 232
VAL A 429
MET A 436
LEU A 292
LEU A 439
 GLY  A 232 ( 0.0A)
VAL  A 429 ( 0.6A)
MET  A 436 ( 0.0A)
LEU  A 292 ( 0.5A)
LEU  A 439 ( 0.6A)
 1.43A 3h52D-3ulkA:
undetectable		 3h52D-3ulkA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HCN_A_CHDA3_0
(FERROCHELATASE,
MITOCHONDRIAL)		 4yzr POLYKETIDE
BIOSYNTHESIS
CYTOCHROME P450 PKSS
(Bacillus
subtilis) 		4 / 7 MET A 234
LEU A 216
ARG A 103
GLY A 354
 MET  A 234 ( 0.0A)
LEU  A 216 ( 0.6A)
ARG  A 103 (-0.6A)
GLY  A 354 (-0.0A)
 1.02A 3hcnA-4yzrA:
undetectable		 3hcnA-4yzrA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HM1_A_J3ZA2_1
(ESTROGEN RECEPTOR)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		5 / 12 THR A 306
ALA A 309
LEU A  67
LEU A  74
MET A 430
 THR  A 306 ( 0.8A)
ALA  A 309 ( 0.0A)
LEU  A  67 ( 0.5A)
LEU  A  74 ( 0.6A)
MET  A 430 ( 0.0A)
 1.16A 3hm1A-4mwtA:
undetectable		 3hm1A-4mwtA:
20.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IAK_A_EV1A415_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		8 / 9 TYR A 159
ASN A 321
ILE A 336
PHE A 340
MET A 357
GLN A 369
PHE A 372
ILE A 376
 TYR  A 159 (-1.3A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
ILE  A 376 (-0.6A)
 0.53A 3iakA-3sl5A:
51.9		 3iakA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IAK_A_EV1A415_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		8 / 9 TYR A 159
MET A 273
ASN A 321
ILE A 336
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.73A 3iakA-3sl5A:
51.9		 3iakA-3sl5A:
94.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IX9_A_MTXA200_1
(DIHYDROFOLATE
REDUCTASE)		 5exk LIPOYL SYNTHASE
(Mycobacterium
tuberculosis) 		5 / 12 ILE A 243
ALA A 295
GLU A 153
LEU A 155
VAL A 244
 None
None
None
MET  A 404 ( 4.6A)
None
 1.13A 3ix9A-5exkA:
undetectable		 3ix9A-5exkA:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 1p1m HYPOTHETICAL PROTEIN
TM0936
(Thermotoga
maritima) 		5 / 12 VAL A 112
ASP A 113
THR A 189
GLY A 137
LEU A 138
 None
None
None
MET  A5001 ( 3.8A)
None
 1.31A 3j6pB-1p1mA:
0.1		 3j6pB-1p1mA:
23.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_A_VIAA901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 9 TYR A 159
HIS A 160
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 1.01A 3jwqA-3sl5A:
39.2		 3jwqA-3sl5A:
28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_B_VIAB901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 11 TYR A 159
HIS A 160
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.94A 3jwqB-3sl5A:
39.0
3jwqC-3sl5A:
39.2		 3jwqB-3sl5A:
28.41
3jwqC-3sl5A:
28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_C_VIAC901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 7 TYR A 159
HIS A 160
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.91A 3jwqC-3sl5A:
39.2		 3jwqC-3sl5A:
28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_D_VIAD901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		6 / 11 TYR A 159
HIS A 160
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 1.01A 3jwqA-3sl5A:
39.2
3jwqD-3sl5A:
38.8		 3jwqA-3sl5A:
28.41
3jwqD-3sl5A:
28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K4V_D_ROCD201_4
(HIV-1 PROTEASE)		 5exk LIPOYL SYNTHASE
(Mycobacterium
tuberculosis) 		3 / 3 ARG A  83
VAL A  54
THR A 121
 None
None
MET  A 404 (-3.7A)
 0.76A 3k4vD-5exkA:
undetectable		 3k4vD-5exkA:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSF_B_PZIB802_0
(GLUTAMATE RECEPTOR 2)		 4io6 AVGLUR1 LIGAND
BINDING DOMAIN
(Adineta
vaga) 		3 / 3 SER A  17
ASP A  85
ASN A 105
 None
MET  A 301 (-4.7A)
MET  A 301 ( 4.9A)
 0.85A 3lsfB-4io6A:
27.5
3lsfE-4io6A:
27.7		 3lsfB-4io6A:
28.83
3lsfE-4io6A:
28.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSF_E_PZIE802_0
(GLUTAMATE RECEPTOR 2)		 4io6 AVGLUR1 LIGAND
BINDING DOMAIN
(Adineta
vaga) 		3 / 3 ASP A  85
ASN A 105
SER A  17
 MET  A 301 (-4.7A)
MET  A 301 ( 4.9A)
None
 0.80A 3lsfB-4io6A:
27.5
3lsfE-4io6A:
27.7		 3lsfB-4io6A:
28.83
3lsfE-4io6A:
28.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)		 3gxa OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 6 LEU A 126
GLU A 231
PRO A 232
ARG A 156
 None
None
None
MET  A 296 (-3.2A)
 1.13A 3ltwA-3gxaA:
undetectable		 3ltwA-3gxaA:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)		 3ir1 OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 6 LEU A 126
GLU A 231
PRO A 232
ARG A 156
 None
None
None
MET  A 600 (-3.2A)
 1.13A 3ltwA-3ir1A:
undetectable		 3ltwA-3ir1A:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MIH_A_CUA358_0
(PEPTIDYL-GLYCINE
ALPHA-AMIDATING
MONOOXYGENASE)		 1joi AZURIN
(Pseudomonas
fluorescens) 		3 / 3 HIS A 117
HIS A  46
MET A  44
 HIS  A 117 (-0.9A)
HIS  A  46 (-0.9A)
MET  A  44 ( 0.0A)
 0.98A 3mihA-1joiA:
undetectable		 3mihA-1joiA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MNO_A_DEXA784_1
(GLUCOCORTICOID
RECEPTOR)		 5wo6 TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 6
(Rattus
norvegicus) 		5 / 12 GLY A 448
VAL A 437
MET A 434
ILE A 556
PHE A 552
 GLY  A 448 ( 0.0A)
VAL  A 437 ( 0.6A)
MET  A 434 ( 0.0A)
ILE  A 556 ( 0.7A)
PHE  A 552 ( 1.3A)
 1.41A 3mnoA-5wo6A:
undetectable		 3mnoA-5wo6A:
15.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NJZ_A_SALA370_1
(GENTISATE
1,2-DIOXYGENASE)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		5 / 12 ALA A 280
HIS A 235
HIS A 150
HIS A  69
LEU A 202
 MET  A 600 (-3.4A)
MET  A 600 (-4.4A)
MET  A 600 (-4.1A)
MG  A 500 (-3.6A)
MET  A 600 (-3.7A)
 1.25A 3njzA-2qs8A:
0.0		 3njzA-2qs8A:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OLS_B_ESTB600_1
(ESTROGEN RECEPTOR
BETA)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 12 MET A 286
LEU A 283
LEU A 279
ILE A 307
LEU A 300
 MET  A 286 ( 0.0A)
LEU  A 283 ( 0.6A)
LEU  A 279 ( 0.6A)
ILE  A 307 ( 0.4A)
LEU  A 300 ( 0.6A)
 1.18A 3olsB-3sl5A:
undetectable		 3olsB-3sl5A:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PP7_B_SVRB499_1
(PYRUVATE KINASE)		 1d6s O-ACETYLSERINE
SULFHYDRYLASE
(Salmonella
enterica) 		5 / 10 THR A 113
PRO A  67
GLY A  70
GLY A 121
ALA A 122
 None
None
MET  A 401 (-4.2A)
None
None
 1.23A 3pp7B-1d6sA:
4.2		 3pp7B-1d6sA:
21.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QXV_E_MTXE2000_1
(ANTI-METHOTREXATE
CDR1-4 GRAFT VHH)		 5gru DIABODY PROTEIN
(Mus
musculus) 		5 / 12 ALA L 153
SER L 214
SER L 215
MET L 125
ALA L 146
 ALA  L 153 ( 0.0A)
SER  L 214 ( 0.0A)
SER  L 215 ( 0.0A)
MET  L 125 ( 0.0A)
ALA  L 146 ( 0.0A)
 1.25A 3qxvE-5gruL:
16.2		 3qxvE-5gruL:
44.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RET_A_SALA201_1
(SALICYLATE
BIOSYNTHESIS PROTEIN
PCHB)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		5 / 10 ALA A 211
VAL A 107
MET A 110
ILE A 205
ILE A 193
 ALA  A 211 ( 0.0A)
VAL  A 107 ( 0.6A)
MET  A 110 ( 0.0A)
ILE  A 205 ( 0.7A)
ILE  A 193 ( 0.6A)
 1.25A 3retA-2rciA:
undetectable
3retB-2rciA:
undetectable		 3retA-2rciA:
18.27
3retB-2rciA:
18.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFA_A_SAMA406_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE N)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		10 / 12 PHE A 131
CYH A 132
MET A 176
GLU A 180
PRO A 181
HIS A 235
VAL A 280
ILE A 309
TRP A 311
ASN A 312
 5AD  A 503 (-4.6A)
SF4  A 502 ( 2.2A)
A  C  37 ( 3.7A)
MET  A 501 (-4.0A)
MET  A 501 ( 4.9A)
5AD  A 503 (-3.7A)
5AD  A 503 (-4.8A)
5AD  A 503 (-4.1A)
5AD  A 503 (-4.0A)
SMC  A 355 (-3.7A)
 0.64A 3rfaA-5hr6A:
50.5		 3rfaA-5hr6A:
99.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFA_A_SAMA406_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE N)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		10 / 12 PHE A 131
CYH A 132
MET A 176
GLU A 180
PRO A 181
SER A 213
HIS A 235
VAL A 280
TRP A 311
ASN A 312
 5AD  A 503 (-4.6A)
SF4  A 502 ( 2.2A)
A  C  37 ( 3.7A)
MET  A 501 (-4.0A)
MET  A 501 ( 4.9A)
MET  A 501 ( 3.3A)
5AD  A 503 (-3.7A)
5AD  A 503 (-4.8A)
5AD  A 503 (-4.0A)
SMC  A 355 (-3.7A)
 0.76A 3rfaA-5hr6A:
50.5		 3rfaA-5hr6A:
99.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFA_B_SAMB406_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE N)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		8 / 12 PHE A 131
CYH A 132
MET A 176
GLU A 180
PRO A 181
SER A 211
SER A 213
TRP A 311
 5AD  A 503 (-4.6A)
SF4  A 502 ( 2.2A)
A  C  37 ( 3.7A)
MET  A 501 (-4.0A)
MET  A 501 ( 4.9A)
MET  A 501 (-2.5A)
MET  A 501 ( 3.3A)
5AD  A 503 (-4.0A)
 0.58A 3rfaB-5hr6A:
52.8		 3rfaB-5hr6A:
99.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFA_B_SAMB406_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE N)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		11 / 12 PHE A 131
CYH A 132
MET A 176
GLU A 180
PRO A 181
SER A 211
SER A 233
HIS A 235
VAL A 280
TRP A 311
ASN A 312
 5AD  A 503 (-4.6A)
SF4  A 502 ( 2.2A)
A  C  37 ( 3.7A)
MET  A 501 (-4.0A)
MET  A 501 ( 4.9A)
MET  A 501 (-2.5A)
MET  A 501 ( 2.6A)
5AD  A 503 (-3.7A)
5AD  A 503 (-4.8A)
5AD  A 503 (-4.0A)
SMC  A 355 (-3.7A)
 0.31A 3rfaB-5hr6A:
52.8		 3rfaB-5hr6A:
99.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S68_A_SAMA228_1
(CATECHOL
O-METHYLTRANSFERASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 ASN A 293
VAL A 294
MET A 224
ASN A 225
HIS A 220
 ASN  A 293 ( 0.6A)
VAL  A 294 ( 0.6A)
MET  A 224 ( 0.0A)
ASN  A 225 ( 0.6A)
HIS  A 220 ( 1.0A)
 1.48A 3s68A-5nqfA:
undetectable		 3s68A-5nqfA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SJ0_X_DXCX75_0
(CYTOCHROME C7)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		4 / 7 ILE A 185
PHE A 299
MET A 250
GLY A 247
 ILE  A 185 ( 0.7A)
PHE  A 299 ( 1.3A)
MET  A 250 ( 0.0A)
GLY  A 247 ( 0.0A)
 1.13A 3sj0X-5gprA:
undetectable		 3sj0X-5gprA:
9.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3S_D_9PLD1_1
(CYTOCHROME P450 2A13)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		4 / 8 ALA A  49
PHE A  50
ALA A  13
THR A 294
 None
MET  A1298 (-3.8A)
None
None
 0.83A 3t3sD-1wkmA:
undetectable		 3t3sD-1wkmA:
19.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TVX_A_PNXA902_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4A)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		9 / 9 TYR A 159
LEU A 319
ASN A 321
PRO A 322
THR A 333
ILE A 336
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.46A 3tvxA-3sl5A:
51.5		 3tvxA-3sl5A:
85.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TVX_B_PNXB902_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4A)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		7 / 7 TYR A 159
ASN A 321
ILE A 336
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.52A 3tvxB-3sl5A:
51.6		 3tvxB-3sl5A:
85.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UAW_A_ADNA236_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.90A 3uawA-4g41A:
23.9		 3uawA-4g41A:
25.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UAW_A_ADNA236_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.95A 3uawA-4g41A:
23.9		 3uawA-4g41A:
25.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UAW_A_ADNA236_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.80A 3uawA-4g41A:
23.9		 3uawA-4g41A:
25.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UAY_A_ADNA236_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.96A 3uayA-4g41A:
24.1		 3uayA-4g41A:
25.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFG_B_LEUB289_0
(GLYCYL-TRNA
SYNTHETASE ALPHA
SUBUNIT)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		3 / 3 PHE A 131
SER A 213
SER A 233
 5AD  A 503 (-4.6A)
MET  A 501 ( 3.3A)
MET  A 501 ( 2.6A)
 0.95A 3ufgB-5hr6A:
undetectable		 3ufgB-5hr6A:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UG2_A_IREA1_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		7 / 12 VAL A  39
ALA A  52
LYS A  54
LEU A 103
MET A 105
GLY A 111
LEU A 160
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
LEU  A 103 ( 0.6A)
MET  A 105 (-0.0A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
 0.90A 3ug2A-5d7aA:
16.0		 3ug2A-5d7aA:
25.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UZZ_B_ASDB501_1
(3-OXO-5-BETA-STEROID
4-DEHYDROGENASE)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		4 / 8 TYR A 481
HIS A 337
TRP A 527
LEU A 475
 MET  A 807 ( 4.9A)
None
None
None
 1.39A 3uzzB-5nfhA:
undetectable		 3uzzB-5nfhA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_A_T1CA404_1
(TETX2 PROTEIN)		 4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima) 		5 / 12 GLY A 167
ALA A 128
GLY A 129
ASN A 210
MET A 234
 GLY  A 167 ( 0.0A)
ALA  A 128 ( 0.0A)
GLY  A 129 ( 0.0A)
ASN  A 210 ( 0.6A)
MET  A 234 ( 0.0A)
 1.23A 3v3oA-4ursA:
undetectable		 3v3oA-4ursA:
19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_B_T1CB405_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 12 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.11A 3v3oB-5gprA:
undetectable		 3v3oB-5gprA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_D_T1CD401_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 10 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.18A 3v3oD-5gprA:
undetectable		 3v3oD-5gprA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VRM_A_VD3A502_1
(VITAMIN D(3)
25-HYDROXYLASE)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		5 / 12 ILE A 519
ILE A 542
ALA A 544
PRO A 247
ILE A 248
 MET  A 807 ( 4.4A)
None
None
MET  A 807 ( 4.7A)
MET  A 807 (-4.8A)
 0.97A 3vrmA-5nfhA:
undetectable		 3vrmA-5nfhA:
22.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W6H_A_AZMA303_1
(CARBONIC ANHYDRASE 1)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 GLN A 332
HIS A  69
HIS A  71
LEU A 202
 None
MG  A 500 (-3.6A)
MG  A 500 (-3.4A)
MET  A 600 (-3.7A)
 0.97A 3w6hA-2qs8A:
undetectable		 3w6hA-2qs8A:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W6H_A_AZMA303_1
(CARBONIC ANHYDRASE 1)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 HIS A 237
HIS A 235
HIS A 255
LEU A 202
 MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MET  A 600 (-3.7A)
 0.84A 3w6hA-2qs8A:
undetectable		 3w6hA-2qs8A:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W6H_A_AZMA303_1
(CARBONIC ANHYDRASE 1)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 HIS A 255
HIS A 237
HIS A 235
LEU A 202
 MET  A 600 ( 4.3A)
MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 (-3.7A)
 1.04A 3w6hA-2qs8A:
undetectable		 3w6hA-2qs8A:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WIP_C_ACHC301_0
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		4 / 8 TYR A 155
TYR A 151
ARG A 347
MET A 349
 TYR  A 155 ( 1.3A)
TYR  A 151 ( 1.3A)
ARG  A 347 ( 0.6A)
MET  A 349 ( 0.0A)
 1.49A 3wipC-4mwtA:
undetectable
3wipD-4mwtA:
undetectable		 3wipC-4mwtA:
18.71
3wipD-4mwtA:
18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WIP_D_ACHD301_0
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		4 / 8 TYR A 155
TYR A 151
ARG A 347
MET A 349
 TYR  A 155 ( 1.3A)
TYR  A 151 ( 1.3A)
ARG  A 347 ( 0.6A)
MET  A 349 ( 0.0A)
 1.48A 3wipD-4mwtA:
undetectable
3wipE-4mwtA:
undetectable		 3wipD-4mwtA:
18.71
3wipE-4mwtA:
18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WQV_A_GCSA501_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 11 PHE A 184
GLY A 267
TRP A 268
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
ARG A 439
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
ARG  A 439 ( 0.6A)
TRP  A 532 ( 0.5A)
 0.44A 3wqvA-5gprA:
43.0		 3wqvA-5gprA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WQW_A_GCSA501_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 11 PHE A 184
GLY A 267
TRP A 268
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
ARG A 439
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
ARG  A 439 ( 0.6A)
TRP  A 532 ( 0.5A)
 0.47A 3wqwA-5gprA:
43.0		 3wqwA-5gprA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_A_T1CA392_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.13A 4a6nA-5gprA:
undetectable		 4a6nA-5gprA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_B_T1CB392_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.13A 4a6nB-5gprA:
undetectable		 4a6nB-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_C_T1CC392_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.13A 4a6nC-5gprA:
undetectable		 4a6nC-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_A_MIYA391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 10 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.22A 4a99A-5gprA:
undetectable		 4a99A-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_B_MIYB391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.19A 4a99B-5gprA:
undetectable		 4a99B-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_C_MIYC391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.21A 4a99C-5gprA:
undetectable		 4a99C-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_D_MIYD391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.21A 4a99D-5gprA:
undetectable		 4a99D-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BLV_A_SAMA1281_1
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE J)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		4 / 6 HIS A  52
HIS A 100
ASP A 130
ASP A  50
 None
None
None
MET  A 600 (-4.3A)
 1.29A 4blvA-2x1mA:
undetectable		 4blvA-2x1mA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BLV_A_SAMA1281_1
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE J)		 3gxa OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 6 HIS A 100
SER A 152
GLU A 110
ASP A 150
 MET  A 296 (-3.6A)
None
None
None
 1.34A 4blvA-3gxaA:
undetectable		 4blvA-3gxaA:
24.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
 MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
 1.43A 4cttA-3r6yA:
undetectable
4cttB-3r6yA:
undetectable		 4cttA-3r6yA:
22.39
4cttB-3r6yA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D9H_A_ADNA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.72A 4d9hA-4g41A:
23.9		 4d9hA-4g41A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DA7_A_AC2A301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 10 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.77A 4da7A-4g41A:
23.8		 4da7A-4g41A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.78A 4danA-4g41A:
23.4		 4danA-4g41A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 12 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
 GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.83A 4danA-4g41A:
23.4
4danB-4g41A:
23.4		 4danA-4g41A:
25.86
4danB-4g41A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4H9M_A_HAEA929_1
(UREASE)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		5 / 5 HIS A  69
HIS A 150
HIS A 235
HIS A 255
ASP A 328
 MG  A 500 (-3.6A)
MET  A 600 (-4.1A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MG  A 500 ( 2.8A)
 1.28A 4h9mA-2qs8A:
21.0		 4h9mA-2qs8A:
19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HOJ_A_ACTA303_0
(REGF PROTEIN)		 3gxa OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 5 VAL A 157
ARG A 156
MET A 160
GLU A 231
 None
MET  A 296 (-3.2A)
None
None
 1.24A 4hojA-3gxaA:
undetectable		 4hojA-3gxaA:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HOJ_A_ACTA303_0
(REGF PROTEIN)		 3ir1 OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 5 VAL A 157
ARG A 156
MET A 160
GLU A 231
 None
MET  A 600 (-3.2A)
None
None
 1.25A 4hojA-3ir1A:
undetectable		 4hojA-3ir1A:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HOJ_A_ACTA303_0
(REGF PROTEIN)		 4c9g ADP, ATP CARRIER
PROTEIN 2
(Saccharomyces
cerevisiae) 		4 / 5 VAL A 251
ARG A 254
MET A 255
GLU A  56
 VAL  A 251 ( 0.6A)
ARG  A 254 ( 0.6A)
MET  A 255 (-0.0A)
GLU  A  56 ( 0.6A)
 0.82A 4hojA-4c9gA:
undetectable		 4hojA-4c9gA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HXY_B_ACAB502_1
(PLM1)		 3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE
(Citrus
x
microcarpa) 		4 / 7 VAL A  31
GLN A  33
TYR A  36
MET A  70
 VAL  A  31 ( 0.6A)
GLN  A  33 ( 0.6A)
TYR  A  36 ( 1.3A)
MET  A  70 ( 0.0A)
 1.16A 4hxyB-3wd7A:
undetectable		 4hxyB-3wd7A:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I22_A_IREA9001_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		9 / 12 GLY A  32
VAL A  39
ALA A  52
LEU A 103
MET A 105
GLY A 111
ASP A 115
LEU A 160
ASP A 171
 GLY  A  32 ( 0.0A)
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LEU  A 103 ( 0.6A)
MET  A 105 (-0.0A)
GLY  A 111 (-0.0A)
ASP  A 115 (-0.6A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 0.94A 4i22A-5d7aA:
14.3		 4i22A-5d7aA:
25.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I22_A_IREA9001_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		9 / 12 GLY A  32
VAL A  39
ALA A  52
LYS A  54
LEU A 103
MET A 105
GLY A 111
LEU A 160
ASP A 171
 GLY  A  32 ( 0.0A)
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
LEU  A 103 ( 0.6A)
MET  A 105 (-0.0A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 0.83A 4i22A-5d7aA:
14.3		 4i22A-5d7aA:
25.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IIZ_B_LURB201_1
(TRANSTHYRETIN)		 1d6s O-ACETYLSERINE
SULFHYDRYLASE
(Salmonella
enterica) 		4 / 8 MET A  91
LEU A  87
THR A  68
LEU A  64
 None
None
MET  A 401 (-3.7A)
None
 0.87A 4iizB-1d6sA:
undetectable		 4iizB-1d6sA:
19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K37_A_SAMA504_0
(ANAEROBIC
SULFATASE-MATURATING
ENZYME)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		5 / 11 CYH A 132
GLU A 180
SER A 233
VAL A 280
ILE A 309
 SF4  A 502 ( 2.2A)
MET  A 501 (-4.0A)
MET  A 501 ( 2.6A)
5AD  A 503 (-4.8A)
5AD  A 503 (-4.1A)
 0.52A 4k37A-5hr6A:
4.2		 4k37A-5hr6A:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KMM_B_CHDB503_0
(FERROCHELATASE,
MITOCHONDRIAL)		 1wly 2-HALOACRYLATE
REDUCTASE
(Burkholderia
sp.
WS) 		4 / 5 MET A 127
LEU A 289
ARG A  87
SER A 326
 MET  A 127 ( 0.0A)
LEU  A 289 ( 0.6A)
ARG  A  87 ( 0.6A)
SER  A 326 ( 0.0A)
 1.49A 4kmmB-1wlyA:
3.9		 4kmmB-1wlyA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOS_A_4KOA201_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 12 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.34A 4kosA-1v0fA:
undetectable		 4kosA-1v0fA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOV_A_KOVA204_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 12 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.36A 4kovA-1v0fA:
undetectable		 4kovA-1v0fA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOW_A_CFXA204_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 12 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.34A 4kowA-1v0fA:
0.0		 4kowA-1v0fA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOX_A_CLSA205_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 11 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.38A 4koxA-1v0fA:
0.0		 4koxA-1v0fA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOY_A_CSCA214_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 11 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.37A 4koyA-1v0fA:
undetectable		 4koyA-1v0fA:
12.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KS8_A_B49A701_1
(SERINE/THREONINE-PRO
TEIN KINASE PAK 6)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 10 ALA A  52
MET A 105
PHE A 107
GLY A 111
LEU A 160
ASP A 171
 ALA  A  52 (-0.0A)
MET  A 105 (-0.0A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 1.03A 4ks8A-5d7aA:
29.9		 4ks8A-5d7aA:
37.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L9I_A_8PRA601_1
(RHODOPSIN KINASE)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 VAL A 164
ALA A 177
LEU A 181
MET A 227
 VAL  A 164 ( 0.6A)
ALA  A 177 ( 0.0A)
LEU  A 181 ( 0.6A)
MET  A 227 ( 0.0A)
 0.28A 4l9iA-3o96A:
9.2		 4l9iA-3o96A:
29.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LHM_A_AZZA510_1
(THYMIDINE
PHOSPHORYLASE)		 5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE
(Bacillus
subtilis) 		8 / 11 THR A  84
TYR A 165
ARG A 168
VAL A 174
ILE A 180
SER A 183
MET A 208
LEU A 217
 THR  A  84 ( 0.8A)
TYR  A 165 ( 1.3A)
ARG  A 168 ( 0.6A)
VAL  A 174 ( 0.5A)
ILE  A 180 ( 0.7A)
SER  A 183 ( 0.0A)
MET  A 208 ( 0.0A)
LEU  A 217 ( 0.6A)
 0.63A 4lhmA-5ep8A:
52.9		 4lhmA-5ep8A:
45.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LMN_A_EUIA503_1
(DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		5 / 12 MET A 105
ASN A 158
ASP A 171
PHE A 172
GLY A 173
 MET  A 105 (-0.0A)
ASN  A 158 ( 0.6A)
ASP  A 171 ( 0.5A)
PHE  A 172 ( 1.3A)
GLY  A 173 ( 0.0A)
 1.00A 4lmnA-5d7aA:
29.6		 4lmnA-5d7aA:
30.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LNW_A_T3A501_2
(THYROID HORMONE
RECEPTOR ALPHA)		 2pk2 CYCLIN-T1, PROTEIN
TAT
(Equine
infectious
anemia
virus;
Homo
sapiens) 		3 / 3 ILE A 105
MET A  48
ARG A  51
 ILE  A 105 ( 0.7A)
MET  A  48 ( 0.0A)
ARG  A  51 ( 0.6A)
 0.90A 4lnwA-2pk2A:
undetectable		 4lnwA-2pk2A:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LNX_A_T3A502_2
(THYROID HORMONE
RECEPTOR ALPHA)		 2pk2 CYCLIN-T1, PROTEIN
TAT
(Equine
infectious
anemia
virus;
Homo
sapiens) 		3 / 3 ILE A 105
MET A  48
ARG A  51
 ILE  A 105 ( 0.7A)
MET  A  48 ( 0.0A)
ARG  A  51 ( 0.6A)
 0.89A 4lnxA-2pk2A:
1.8		 4lnxA-2pk2A:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M11_C_MXMC606_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		3 / 3 LEU A 358
ARG A 359
MET A 129
 LEU  A 358 (-0.5A)
ARG  A 359 ( 0.6A)
MET  A 129 ( 0.0A)
 1.00A 4m11C-4flxA:
undetectable		 4m11C-4flxA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MF6_A_BEZA303_0
(GLUTATHIONE
S-TRANSFERASE DOMAIN)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		4 / 5 THR A 284
PHE A 243
ASN A 480
TYR A 481
 None
None
None
MET  A 807 ( 4.9A)
 1.38A 4mf6A-5nfhA:
undetectable		 4mf6A-5nfhA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM4_B_8PRB603_2
(TRANSPORTER)		 2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1
(Homo
sapiens) 		3 / 3 SER A  52
MET A  55
ASP A 184
 SER  A  52 ( 0.0A)
MET  A  55 ( 0.0A)
ASP  A 184 (-0.6A)
 0.96A 4mm4B-2b92A:
0.0		 4mm4B-2b92A:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM4_B_8PRB603_2
(TRANSPORTER)		 2p5d UPF0310 PROTEIN
MJECL36
(Methanocaldococc
us
jannaschii) 		3 / 3 SER A 125
MET A 129
ASP A 140
 SER  A 125 ( 0.0A)
MET  A 129 ( 0.0A)
ASP  A 140 ( 0.6A)
 0.71A 4mm4B-2p5dA:
undetectable		 4mm4B-2p5dA:
14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O1Z_B_MXMB807_1
(PROSTAGLANDIN G/H
SYNTHASE 1)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		6 / 12 MET C 384
VAL C 248
LEU C 246
LEU C 344
PHE C 295
ALA C 289
 MET  C 384 ( 0.0A)
VAL  C 248 ( 0.6A)
LEU  C 246 ( 0.6A)
LEU  C 344 ( 0.6A)
PHE  C 295 ( 1.3A)
ALA  C 289 ( 0.0A)
 1.50A 4o1zB-3ghgC:
undetectable		 4o1zB-3ghgC:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OK1_A_198A1001_2
(ANDROGEN RECEPTOR)		 2j5b TYROSYL-TRNA
SYNTHETASE
(Acanthamoeba
polyphaga
mimivirus) 		4 / 8 LEU A 182
ASN A 190
MET A 127
ILE A 204
 LEU  A 182 (-0.6A)
ASN  A 190 ( 0.6A)
MET  A 127 ( 0.0A)
ILE  A 204 ( 0.7A)
 0.87A 4ok1A-2j5bA:
undetectable		 4ok1A-2j5bA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OKX_A_198A1002_2
(ANDROGEN RECEPTOR)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 6 LEU A 369
MET A 376
LEU A 157
ILE A 151
 LEU  A 369 ( 0.5A)
MET  A 376 ( 0.0A)
LEU  A 157 ( 0.6A)
ILE  A 151 ( 0.6A)
 1.11A 4okxA-3r6yA:
2.0		 4okxA-3r6yA:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLB_A_TRPA901_0
(PROTEIN ARGONAUTE-2)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		3 / 3 VAL A  83
ALA A  92
PHE A  50
 None
None
MET  A1298 (-3.8A)
 0.89A 4olbA-1wkmA:
undetectable		 4olbA-1wkmA:
15.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PL1_A_SAMA401_0
(DUAL-SPECIFICITY RNA
METHYLTRANSFERASE
RLMN)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		10 / 11 PHE A 131
MET A 176
GLU A 180
PRO A 181
SER A 211
SER A 233
HIS A 235
ILE A 309
TRP A 311
ASN A 312
 5AD  A 503 (-4.6A)
A  C  37 ( 3.7A)
MET  A 501 (-4.0A)
MET  A 501 ( 4.9A)
MET  A 501 (-2.5A)
MET  A 501 ( 2.6A)
5AD  A 503 (-3.7A)
5AD  A 503 (-4.1A)
5AD  A 503 (-4.0A)
SMC  A 355 (-3.7A)
 0.46A 4pl1A-5hr6A:
49.5		 4pl1A-5hr6A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PL1_B_SAMB401_0
(DUAL-SPECIFICITY RNA
METHYLTRANSFERASE
RLMN)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		9 / 10 CYH A 132
MET A 176
GLU A 180
PRO A 181
SER A 211
SER A 233
HIS A 235
TRP A 311
ASN A 312
 SF4  A 502 ( 2.2A)
A  C  37 ( 3.7A)
MET  A 501 (-4.0A)
MET  A 501 ( 4.9A)
MET  A 501 (-2.5A)
MET  A 501 ( 2.6A)
5AD  A 503 (-3.7A)
5AD  A 503 (-4.0A)
SMC  A 355 (-3.7A)
 0.41A 4pl1B-5hr6A:
51.9		 4pl1B-5hr6A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PL1_B_SAMB401_0
(DUAL-SPECIFICITY RNA
METHYLTRANSFERASE
RLMN)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		7 / 10 CYH A 132
MET A 176
SER A 233
HIS A 235
GLU A 278
TRP A 311
ASN A 312
 SF4  A 502 ( 2.2A)
A  C  37 ( 3.7A)
MET  A 501 ( 2.6A)
5AD  A 503 (-3.7A)
5AD  A 503 (-3.1A)
5AD  A 503 (-4.0A)
SMC  A 355 (-3.7A)
 0.85A 4pl1B-5hr6A:
51.9		 4pl1B-5hr6A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QMZ_A_B49A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 12 GLY A  32
VAL A  39
ALA A  52
MET A 105
GLY A 109
LEU A 160
 GLY  A  32 ( 0.0A)
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
MET  A 105 (-0.0A)
GLY  A 109 ( 0.0A)
LEU  A 160 (-0.6A)
 0.51A 4qmzA-5d7aA:
24.6		 4qmzA-5d7aA:
43.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R20_B_AERB602_1
(CYTOCHROME P450
FAMILY 17
POLYPEPTIDE 2)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 9 ALA A  49
PHE A  50
ILE A  81
VAL A  96
THR A 294
 None
MET  A1298 (-3.8A)
None
None
None
 1.26A 4r20B-1wkmA:
undetectable		 4r20B-1wkmA:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R7I_A_STIA1001_2
(MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR)		 1xs5 MEMBRANE LIPOPROTEIN
TPN32
(Treponema
pallidum) 		4 / 5 LEU A  14
VAL A  51
TYR A  44
ARG A 221
 None
None
MET  A 301 (-3.7A)
None
 1.00A 4r7iA-1xs5A:
undetectable		 4r7iA-1xs5A:
24.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R7L_A_SHHA709_1
(LEUKOTRIENE A-4
HYDROLASE)		 4ib2 PUTATIVE LIPOPROTEIN
([Ruminococcus]
gnavus) 		5 / 12 ALA A 230
HIS A  48
HIS A 115
GLU A 117
LEU A 153
 None
MET  A 305 (-4.6A)
None
MET  A 305 (-2.6A)
None
 1.33A 4r7lA-4ib2A:
undetectable		 4r7lA-4ib2A:
18.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_A_TFPA203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		7 / 8 ILE D 100
LEU D 105
MET D 109
MET D 124
ALA D 128
VAL D 136
MET D 144
 ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
MET  D 124 ( 0.0A)
ALA  D 128 ( 0.0A)
VAL  D 136 ( 0.6A)
MET  D 144 ( 0.0A)
 0.80A 4rjdA-4gowD:
12.6		 4rjdA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_A_TFPA203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		4 / 8 PHE D  19
ILE D  27
LEU D  32
MET D  51
 PHE  D  19 ( 1.3A)
ILE  D  27 ( 0.7A)
LEU  D  32 ( 0.6A)
MET  D  51 ( 0.0A)
 0.56A 4rjdA-4gowD:
12.6		 4rjdA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_A_TFPA203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		7 / 8 PHE D  92
ILE D 100
LEU D 105
MET D 109
MET D 124
ALA D 128
VAL D 136
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
MET  D 124 ( 0.0A)
ALA  D 128 ( 0.0A)
VAL  D 136 ( 0.6A)
 0.65A 4rjdA-4gowD:
12.6		 4rjdA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_B_TFPB203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		5 / 7 PHE D  19
LEU D  32
MET D  36
MET D  71
MET D  72
 PHE  D  19 ( 1.3A)
LEU  D  32 ( 0.6A)
MET  D  36 ( 0.0A)
MET  D  71 ( 0.0A)
MET  D  72 ( 0.0A)
 1.16A 4rjdB-4gowD:
12.6		 4rjdB-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_B_TFPB203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		5 / 7 PHE D  19
LEU D  32
MET D  51
MET D  71
MET D  72
 PHE  D  19 ( 1.3A)
LEU  D  32 ( 0.6A)
MET  D  51 ( 0.0A)
MET  D  71 ( 0.0A)
MET  D  72 ( 0.0A)
 0.67A 4rjdB-4gowD:
12.6		 4rjdB-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_B_TFPB203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		7 / 7 PHE D  92
LEU D 105
MET D 109
MET D 124
ALA D 128
MET D 144
MET D 145
 PHE  D  92 ( 1.3A)
LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
MET  D 124 ( 0.0A)
ALA  D 128 ( 0.0A)
MET  D 144 ( 0.0A)
MET  D 145 ( 0.0A)
 0.93A 4rjdB-4gowD:
12.6		 4rjdB-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RTB_A_SAMA501_0
(HYDG PROTEIN)		 4wcx BIOTIN AND THIAMIN
SYNTHESIS ASSOCIATED
(Thermoanaerobact
er
italicus) 		9 / 12 TYR A  96
CYH A  97
ASN A 169
LEU A 191
PHE A 192
LYS A 210
LEU A 236
LEU A 272
ALA A 275
 None
SF4  A 501 (-2.1A)
MET  A 503 (-3.2A)
None
None
SF4  A 501 (-3.3A)
None
None
None
 0.66A 4rtbA-4wcxA:
47.7		 4rtbA-4wcxA:
43.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBP_C_HAEC800_1
(PROTEIN (UREASE
(CHAIN C)))		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		5 / 6 HIS A  69
HIS A  71
HIS A 235
HIS A 255
ASP A 328
 MG  A 500 (-3.6A)
MG  A 500 (-3.4A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MG  A 500 ( 2.8A)
 0.75A 4ubpC-2qs8A:
19.0		 4ubpC-2qs8A:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPN_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
 MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
 1.39A 4upnA-3r6yA:
undetectable
4upnB-3r6yA:
1.3		 4upnA-3r6yA:
22.39
4upnB-3r6yA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W5N_A_IPHA901_0
(PROTEIN ARGONAUTE-2)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		3 / 3 VAL A  83
ALA A  92
PHE A  50
 None
None
MET  A1298 (-3.8A)
 0.89A 4w5nA-1wkmA:
undetectable		 4w5nA-1wkmA:
15.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WCX_C_SAMC503_0
(BIOTIN AND THIAMIN
SYNTHESIS ASSOCIATED)		 4wcx BIOTIN AND THIAMIN
SYNTHESIS ASSOCIATED
(Thermoanaerobact
er
italicus) 		11 / 12 TYR A  96
TYR A  99
GLU A 133
GLY A 135
GLU A 136
PHE A 192
LEU A 236
PRO A 270
LEU A 272
ARG A 273
ALA A 275
 None
MET  A 503 (-3.4A)
MET  A 503 (-3.2A)
MET  A 503 ( 3.6A)
None
None
None
None
None
None
None
 0.75A 4wcxC-4wcxA:
61.5		 4wcxC-4wcxA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WCX_C_SAMC503_1
(BIOTIN AND THIAMIN
SYNTHESIS ASSOCIATED)		 4wcx BIOTIN AND THIAMIN
SYNTHESIS ASSOCIATED
(Thermoanaerobact
er
italicus) 		5 / 6 CYH A  97
ASN A 169
LEU A 191
GLU A 194
LYS A 210
 SF4  A 501 (-2.1A)
MET  A 503 (-3.2A)
None
SF4  A 501 ( 4.9A)
SF4  A 501 (-3.3A)
 0.26A 4wcxC-4wcxA:
61.1		 4wcxC-4wcxA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XI3_D_29SD601_1
(ESTROGEN RECEPTOR)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 12 ALA A 317
TRP A 102
LEU A 175
LEU A 176
MET A 122
 ALA  A 317 ( 0.0A)
TRP  A 102 ( 0.5A)
LEU  A 175 ( 0.6A)
LEU  A 176 ( 0.6A)
MET  A 122 ( 0.0A)
 1.15A 4xi3D-3sl5A:
undetectable		 4xi3D-3sl5A:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XI3_D_29SD601_1
(ESTROGEN RECEPTOR)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		5 / 12 THR A 306
ALA A 309
LEU A  67
LEU A  74
MET A 430
 THR  A 306 ( 0.8A)
ALA  A 309 ( 0.0A)
LEU  A  67 ( 0.5A)
LEU  A  74 ( 0.6A)
MET  A 430 ( 0.0A)
 1.28A 4xi3D-4mwtA:
undetectable		 4xi3D-4mwtA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XK8_A_PQNA844_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A1)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		4 / 7 MET A 122
PHE A 126
ALA A 192
LEU A 191
 MET  A 122 ( 0.0A)
PHE  A 126 ( 1.3A)
ALA  A 192 ( 0.0A)
LEU  A 191 ( 0.6A)
 1.12A 4xk8A-3sl5A:
undetectable		 4xk8A-3sl5A:
18.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z4I_A_IPHA903_0
(PROTEIN ARGONAUTE-2)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		3 / 3 VAL A  83
ALA A  92
PHE A  50
 None
None
MET  A1298 (-3.8A)
 0.90A 4z4iA-1wkmA:
undetectable		 4z4iA-1wkmA:
15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZDZ_A_TPFA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 PHE A 408
ILE A 402
GLY A 254
MET A 343
 PHE  A 408 ( 1.3A)
ILE  A 402 ( 0.4A)
GLY  A 254 ( 0.0A)
MET  A 343 ( 0.0A)
 0.93A 4zdzA-3o96A:
undetectable		 4zdzA-3o96A:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZN7_A_DESA601_1
(ESTROGEN RECEPTOR)		 5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE
(Bacillus
subtilis) 		5 / 12 LEU A 289
ALA A 292
GLU A 291
MET A 233
LEU A 296
 LEU  A 289 ( 0.6A)
ALA  A 292 ( 0.0A)
GLU  A 291 ( 0.6A)
MET  A 233 ( 0.0A)
LEU  A 296 ( 0.5A)
 1.02A 4zn7A-5ep8A:
undetectable		 4zn7A-5ep8A:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AMI_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4qhq LIPOPROTEIN
(Burkholderia
cenocepacia) 		4 / 8 ASN A 204
PHE A  85
SER A  84
TYR A 250
 MET  A 301 (-4.3A)
MET  A 301 (-4.7A)
None
None
 1.20A 5amiB-4qhqA:
undetectable		 5amiB-4qhqA:
15.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E4J_A_DMEA608_1
(ACETYLCHOLINESTERASE)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 9 TYR A 263
TYR A 265
GLU A 187
HIS A 153
GLY A 152
 None
MET  A1298 ( 4.7A)
MN  A 296 ( 2.6A)
MN  A 296 ( 3.3A)
None
 1.21A 5e4jA-1wkmA:
0.4		 5e4jA-1wkmA:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E72_A_SAMA400_0
(N2,
N2-DIMETHYLGUANOSINE
TRNA
METHYLTRANSFERASE)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 12 ILE A 392
PHE A 248
MET A 378
ALA A 278
LEU A 313
 ILE  A 392 ( 0.7A)
PHE  A 248 ( 1.3A)
MET  A 378 ( 0.0A)
ALA  A 278 ( 0.0A)
LEU  A 313 ( 0.5A)
 1.07A 5e72A-3gnrA:
undetectable		 5e72A-3gnrA:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ESJ_A_TPFA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 1u1h 5-METHYLTETRAHYDROPT
EROYLTRIGLUTAMATE--H
OMOCYSTEINE
METHYLTRANSFERASE
(Arabidopsis
thaliana) 		4 / 8 GLY A 438
THR A 436
LEU A 477
MET A 554
 MET  A 772 (-3.1A)
None
None
None
 0.69A 5esjA-1u1hA:
0.0		 5esjA-1u1hA:
22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ESJ_A_TPFA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 8 PHE A 408
ILE A 402
GLY A 254
MET A 343
 PHE  A 408 ( 1.3A)
ILE  A 402 ( 0.4A)
GLY  A 254 ( 0.0A)
MET  A 343 ( 0.0A)
 0.92A 5esjA-3o96A:
undetectable		 5esjA-3o96A:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FHR_A_SAMA303_0
(CATECHOL
O-METHYLTRANSFERASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 ASN A 293
VAL A 294
MET A 224
ASN A 225
HIS A 220
 ASN  A 293 ( 0.6A)
VAL  A 294 ( 0.6A)
MET  A 224 ( 0.0A)
ASN  A 225 ( 0.6A)
HIS  A 220 ( 1.0A)
 1.48A 5fhrA-5nqfA:
undetectable		 5fhrA-5nqfA:
18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G48_B_1FLB1375_1
(DNA POLYMERASE III
SUBUNIT BETA)		 5x5l ADER
(Acinetobacter
baumannii) 		5 / 9 LEU A 192
LEU A 214
ILE A 176
LEU A 218
MET A 226
 LEU  A 192 ( 0.6A)
LEU  A 214 ( 0.6A)
ILE  A 176 ( 0.4A)
LEU  A 218 ( 0.6A)
MET  A 226 ( 0.0A)
 1.26A 5g48B-5x5lA:
undetectable		 5g48B-5x5lA:
17.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 11 VAL A 169
LEU A 149
MET A 122
SER A 197
GLY A 237
 VAL  A 169 ( 0.6A)
LEU  A 149 ( 0.6A)
MET  A 122 ( 0.0A)
SER  A 197 ( 0.0A)
GLY  A 237 ( 0.0A)
 1.49A 5g6sA-3sl5A:
0.7
5g6sG-3sl5A:
0.0		 5g6sA-3sl5A:
22.85
5g6sG-3sl5A:
22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 11 VAL A 169
LEU A 149
TYR A 145
MET A 122
GLY A 237
 VAL  A 169 ( 0.6A)
LEU  A 149 ( 0.6A)
TYR  A 145 ( 1.3A)
MET  A 122 ( 0.0A)
GLY  A 237 ( 0.0A)
 1.25A 5g6sA-3sl5A:
0.7
5g6sG-3sl5A:
0.0		 5g6sA-3sl5A:
22.85
5g6sG-3sl5A:
22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 11 VAL A 169
LEU A 149
TYR A 145
MET A 122
GLY A 237
 VAL  A 169 ( 0.6A)
LEU  A 149 ( 0.6A)
TYR  A 145 ( 1.3A)
MET  A 122 ( 0.0A)
GLY  A 237 ( 0.0A)
 1.23A 5g6sB-3sl5A:
undetectable
5g6sC-3sl5A:
0.7		 5g6sB-3sl5A:
22.85
5g6sC-3sl5A:
22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 12 MET A 122
GLY A 237
VAL A 169
LEU A 149
TYR A 145
 MET  A 122 ( 0.0A)
GLY  A 237 ( 0.0A)
VAL  A 169 ( 0.6A)
LEU  A 149 ( 0.6A)
TYR  A 145 ( 1.3A)
 1.25A 5g6sB-3sl5A:
undetectable
5g6sC-3sl5A:
undetectable		 5g6sB-3sl5A:
22.85
5g6sC-3sl5A:
22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 12 MET A 122
SER A 197
GLY A 237
VAL A 169
LEU A 149
 MET  A 122 ( 0.0A)
SER  A 197 ( 0.0A)
GLY  A 237 ( 0.0A)
VAL  A 169 ( 0.6A)
LEU  A 149 ( 0.6A)
 1.49A 5g6sB-3sl5A:
undetectable
5g6sC-3sl5A:
undetectable		 5g6sB-3sl5A:
22.85
5g6sC-3sl5A:
22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 10 VAL A 169
LEU A 149
TYR A 145
MET A 122
GLY A 237
 VAL  A 169 ( 0.6A)
LEU  A 149 ( 0.6A)
TYR  A 145 ( 1.3A)
MET  A 122 ( 0.0A)
GLY  A 237 ( 0.0A)
 1.24A 5g6sD-3sl5A:
0.7
5g6sF-3sl5A:
0.0		 5g6sD-3sl5A:
22.85
5g6sF-3sl5A:
22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 11 VAL A 169
LEU A 149
TYR A 145
MET A 122
GLY A 237
 VAL  A 169 ( 0.6A)
LEU  A 149 ( 0.6A)
TYR  A 145 ( 1.3A)
MET  A 122 ( 0.0A)
GLY  A 237 ( 0.0A)
 1.24A 5g6sE-3sl5A:
0.7
5g6sH-3sl5A:
undetectable		 5g6sE-3sl5A:
22.85
5g6sH-3sl5A:
22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GTR_A_ESTA601_1
(ESTROGEN RECEPTOR)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 12 ALA A 317
LEU A 175
LEU A 176
MET A 122
ILE A 125
 ALA  A 317 ( 0.0A)
LEU  A 175 ( 0.6A)
LEU  A 176 ( 0.6A)
MET  A 122 ( 0.0A)
ILE  A 125 ( 0.6A)
 1.08A 5gtrA-3sl5A:
3.2		 5gtrA-3sl5A:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_D_P06D801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 1u1h 5-METHYLTETRAHYDROPT
EROYLTRIGLUTAMATE--H
OMOCYSTEINE
METHYLTRANSFERASE
(Arabidopsis
thaliana) 		5 / 12 GLY A 696
ALA A 746
VAL A 487
LEU A 735
GLY A 734
 None
None
None
None
MET  A 772 (-3.2A)
 0.84A 5hieD-1u1hA:
undetectable		 5hieD-1u1hA:
17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HWA_A_GCSA302_1
(CHITOSANASE)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		4 / 7 THR A  95
ASP A  50
ASP A 232
GLY A  53
 None
MET  A 600 (-4.3A)
None
None
 0.81A 5hwaA-2x1mA:
undetectable		 5hwaA-2x1mA:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HWA_A_GCSA302_1
(CHITOSANASE)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		4 / 7 THR A 332
ASP A 287
ASP A 476
GLY A 290
 None
MET  A 807 (-3.6A)
None
None
 0.82A 5hwaA-5nfhA:
undetectable		 5hwaA-5nfhA:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HWA_A_GCSA302_1
(CHITOSANASE)		 5urb METHIONINE--TRNA
LIGASE
(Acinetobacter
baumannii) 		4 / 7 THR A  94
ASP A  49
ASP A 253
GLY A  52
 None
MET  A 603 (-3.6A)
None
None
 0.84A 5hwaA-5urbA:
undetectable		 5hwaA-5urbA:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3C_B_AC2B301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.79A 5i3cB-4g41A:
24.9		 5i3cB-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3C_C_AC2C301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
 0.79A 5i3cC-4g41A:
24.8		 5i3cC-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3C_C_AC2C301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
 VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
 0.69A 5i3cC-4g41A:
24.8		 5i3cC-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IKR_A_ID8A601_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		3 / 3 VAL A 132
LEU A  84
MET A 195
 VAL  A 132 ( 0.5A)
LEU  A  84 ( 0.6A)
MET  A 195 ( 0.0A)
 0.89A 5ikrA-4g41A:
undetectable		 5ikrA-4g41A:
17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQD_C_RIOC600_0
(BIFUNCTIONAL AAC/APH)		 4qhq LIPOPROTEIN
(Burkholderia
cenocepacia) 		5 / 12 SER A 111
ASN A 229
GLU A 221
SER A 225
VAL A 200
 MET  A 301 (-3.2A)
MET  A 301 (-3.0A)
None
None
None
 1.33A 5iqdC-4qhqA:
0.9		 5iqdC-4qhqA:
19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JS1_A_IPHA902_0
(PROTEIN ARGONAUTE-2)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		3 / 3 VAL A  83
ALA A  92
PHE A  50
 None
None
MET  A1298 (-3.8A)
 0.88A 5js1A-1wkmA:
undetectable		 5js1A-1wkmA:
15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KBW_A_RBFA201_1
(RIBOFLAVIN
TRANSPORTER RIBU)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 12 GLY A 373
MET A 374
ASN A 426
LEU A 427
ASN A 395
 GLY  A 373 ( 0.0A)
MET  A 374 ( 0.0A)
ASN  A 426 ( 0.6A)
LEU  A 427 ( 0.5A)
ASN  A 395 ( 0.6A)
 1.32A 5kbwA-3gnrA:
1.9		 5kbwA-3gnrA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MUG_A_VIVA301_1
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 5hr6 RLMN METHYLASE
(Escherichia
coli) 		3 / 3 SER A 213
SER A 211
PHE A 131
 MET  A 501 ( 3.3A)
MET  A 501 (-2.5A)
5AD  A 503 (-4.6A)
 0.94A 5mugA-5hr6A:
3.8		 5mugA-5hr6A:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVS_A_ADNA401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		4 / 7 GLU A 280
ALA A 185
PHE A 189
ASN A  53
 MN  A 297 (-2.5A)
MN  A 296 ( 3.9A)
None
MET  A1298 (-3.0A)
 0.83A 5mvsA-1wkmA:
undetectable		 5mvsA-1wkmA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVS_B_ADNB401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		4 / 8 GLU A 280
ALA A 185
PHE A 189
ASN A  53
 MN  A 297 (-2.5A)
MN  A 296 ( 3.9A)
None
MET  A1298 (-3.0A)
 0.84A 5mvsB-1wkmA:
undetectable		 5mvsB-1wkmA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZR_A_PFLA412_1
(PROTON-GATED ION
CHANNEL)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 10 PRO A 273
ILE A 212
MET A 207
VAL A 262
ILE A 366
 PRO  A 273 ( 1.1A)
ILE  A 212 ( 0.6A)
MET  A 207 ( 0.0A)
VAL  A 262 ( 0.6A)
ILE  A 366 ( 0.7A)
 1.40A 5mzrA-5wpiA:
undetectable		 5mzrA-5wpiA:
14.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZR_C_PFLC409_1
(PROTON-GATED ION
CHANNEL)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 10 PRO A 273
ILE A 212
MET A 207
VAL A 262
ILE A 366
 PRO  A 273 ( 1.1A)
ILE  A 212 ( 0.6A)
MET  A 207 ( 0.0A)
VAL  A 262 ( 0.6A)
ILE  A 366 ( 0.7A)
 1.40A 5mzrC-5wpiA:
undetectable		 5mzrC-5wpiA:
14.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZR_D_PFLD410_1
(PROTON-GATED ION
CHANNEL)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 9 PRO A 273
ILE A 212
MET A 207
VAL A 262
ILE A 366
 PRO  A 273 ( 1.1A)
ILE  A 212 ( 0.6A)
MET  A 207 ( 0.0A)
VAL  A 262 ( 0.6A)
ILE  A 366 ( 0.7A)
 1.42A 5mzrD-5wpiA:
undetectable		 5mzrD-5wpiA:
14.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NFP_A_8W5A804_2
(GLUCOCORTICOID
RECEPTOR)		 3sag EXOSOME COMPONENT 10
(Homo
sapiens) 		4 / 4 LEU A 544
MET A 579
ILE A 551
LEU A 512
 LEU  A 544 ( 0.6A)
MET  A 579 ( 0.0A)
ILE  A 551 ( 0.7A)
LEU  A 512 ( 0.6A)
 1.40A 5nfpA-3sagA:
undetectable		 5nfpA-3sagA:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NM5_B_LOCB502_2
(TUBULIN BETA-2B
CHAIN)		 2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1
(Homo
sapiens) 		5 / 12 LEU A  13
MET A  38
ILE A  30
ALA A  27
ILE A  34
 LEU  A  13 ( 0.6A)
MET  A  38 ( 0.0A)
ILE  A  30 ( 0.6A)
ALA  A  27 ( 0.0A)
ILE  A  34 ( 0.6A)
 1.33A 5nm5B-2b92A:
undetectable		 5nm5B-2b92A:
20.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NNW_D_GCSD302_1
(25 KDA PROTEIN
ELICITOR)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		4 / 7 GLY A 152
HIS A 153
ASP A  93
HIS A  62
 None
MN  A 296 ( 3.3A)
MN  A 297 (-2.3A)
MET  A1298 (-3.8A)
 0.83A 5nnwD-1wkmA:
undetectable		 5nnwD-1wkmA:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OM3_B_DXTB501_1
(ALPHA-1-ANTICHYMOTRY
PSIN)		 4qhq LIPOPROTEIN
(Burkholderia
cenocepacia) 		4 / 6 SER A  84
PHE A  85
ASP A  41
HIS A  87
 None
MET  A 301 (-4.7A)
MET  A 301 ( 4.7A)
MET  A 301 (-3.5A)
 1.18A 5om3A-4qhqA:
undetectable
5om3B-4qhqA:
undetectable		 5om3A-4qhqA:
15.77
5om3B-4qhqA:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OV9_A_CVIA608_0
(ACETYLCHOLINESTERASE)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		4 / 7 TYR A 250
ASP A 287
THR A 332
VAL A 471
 MET  A 807 (-3.2A)
MET  A 807 (-3.6A)
None
None
 1.00A 5ov9A-5nfhA:
3.2		 5ov9A-5nfhA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OV9_B_CVIB602_0
(ACETYLCHOLINESTERASE)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		4 / 8 TYR A 250
ASP A 287
THR A 332
VAL A 471
 MET  A 807 (-3.2A)
MET  A 807 (-3.6A)
None
None
 1.02A 5ov9B-5nfhA:
undetectable		 5ov9B-5nfhA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TL8_A_X2NA502_1
(PROTEIN CYP51)		 1k5d RAN-SPECIFIC
GTPASE-ACTIVATING
PROTEIN
(Homo
sapiens) 		5 / 12 PHE B 142
ALA B 148
ALA B  85
MET B  90
THR B 153
 PHE  B 142 ( 1.3A)
ALA  B 148 ( 0.0A)
ALA  B  85 ( 0.0A)
MET  B  90 ( 0.0A)
THR  B 153 ( 0.8A)
 1.25A 5tl8A-1k5dB:
undetectable		 5tl8A-1k5dB:
17.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TL8_A_X2NA502_1
(PROTEIN CYP51)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 ALA A 110
PHE A  50
ALA A  49
ALA A  92
THR A 294
 None
MET  A1298 (-3.8A)
None
None
None
 1.25A 5tl8A-1wkmA:
undetectable		 5tl8A-1wkmA:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TT3_H_EZLH303_1
(ALPHA-CARBONIC
ANHYDRASE)		 2qs8 XAA-PRO DIPEPTIDASE
(Alteromonas
macleodii) 		4 / 8 HIS A 237
HIS A 235
HIS A 255
LEU A 202
 MET  A 600 (-3.9A)
MET  A 600 (-4.4A)
MET  A 600 ( 4.3A)
MET  A 600 (-3.7A)
 0.88A 5tt3H-2qs8A:
undetectable		 5tt3H-2qs8A:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5U4S_A_BEZA301_0
(PUTATIVE SHORT CHAIN
DEHYDROGENASE)		 3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A
(Pyrococcus
furiosus;
Saccharomyces
cerevisiae) 		4 / 7 ILE A 286
LEU A 308
MET A 312
LEU A 309
 ILE  A 286 ( 0.7A)
LEU  A 308 ( 0.6A)
MET  A 312 ( 0.0A)
LEU  A 309 ( 0.6A)
 1.02A 5u4sA-3whlA:
undetectable		 5u4sA-3whlA:
22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5U4S_B_BEZB301_0
(PUTATIVE SHORT CHAIN
DEHYDROGENASE)		 5wo6 TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 6
(Rattus
norvegicus) 		4 / 8 ILE A 189
LEU A 219
MET A 215
LEU A 218
 ILE  A 189 ( 0.7A)
LEU  A 219 ( 0.6A)
MET  A 215 ( 0.0A)
LEU  A 218 ( 0.6A)
 1.02A 5u4sB-5wo6A:
undetectable		 5u4sB-5wo6A:
15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UC3_A_486A801_2
(GLUCOCORTICOID
RECEPTOR)		 2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1
(Homo
sapiens) 		4 / 5 LEU A 208
LEU A 224
MET A 139
TYR A 204
 LEU  A 208 ( 0.6A)
LEU  A 224 ( 0.6A)
MET  A 139 ( 0.0A)
TYR  A 204 ( 1.3A)
 1.44A 5uc3A-2b92A:
undetectable		 5uc3A-2b92A:
13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UC3_A_486A801_2
(GLUCOCORTICOID
RECEPTOR)		 5l5n PLEXIN-A4
(Mus
musculus) 		4 / 5 LEU A 382
LEU A 412
MET A 417
GLN A 259
 LEU  A 382 ( 0.5A)
LEU  A 412 ( 0.5A)
MET  A 417 ( 0.0A)
GLN  A 259 ( 0.6A)
 1.46A 5uc3A-5l5nA:
undetectable		 5uc3A-5l5nA:
5.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V02_R_657R201_0
(CALMODULIN-1
SMALL CONDUCTANCE
CALCIUM-ACTIVATED
POTASSIUM CHANNEL
PROTEIN 2)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 10 LEU D  32
MET D  51
GLU D  54
VAL D  55
ILE D  63
MET D  72
 LEU  D  32 ( 0.6A)
MET  D  51 ( 0.0A)
GLU  D  54 ( 0.5A)
VAL  D  55 ( 0.6A)
ILE  D  63 ( 0.7A)
MET  D  72 ( 0.0A)
 0.71A 5v02B-4gowD:
undetectable
5v02R-4gowD:
14.5		 5v02B-4gowD:
19.86
5v02R-4gowD:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V02_R_657R201_0
(CALMODULIN-1
SMALL CONDUCTANCE
CALCIUM-ACTIVATED
POTASSIUM CHANNEL
PROTEIN 2)		 5ihl 3H56-5 DOMAIN
ANTIBODY (DAB)
(Homo
sapiens) 		5 / 10 ALA B  93
VAL B  37
LEU B  78
MET B  34
ILE B  69
 ALA  B  93 ( 0.0A)
VAL  B  37 ( 0.6A)
LEU  B  78 ( 0.6A)
MET  B  34 ( 0.0A)
ILE  B  69 ( 0.7A)
 1.13A 5v02B-5ihlB:
undetectable
5v02R-5ihlB:
undetectable		 5v02B-5ihlB:
15.45
5v02R-5ihlB:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_E_C2FE3001_0
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 1u1h 5-METHYLTETRAHYDROPT
EROYLTRIGLUTAMATE--H
OMOCYSTEINE
METHYLTRANSFERASE
(Arabidopsis
thaliana) 		5 / 12 GLU A 490
ARG A 493
VAL A 743
LEU A 747
GLY A 734
 MET  A 772 (-3.2A)
None
None
None
MET  A 772 (-3.2A)
 1.14A 5vooE-1u1hA:
8.3		 5vooE-1u1hA:
18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUS_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
 MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
 1.40A 5vusA-3r6yA:
undetectable
5vusB-3r6yA:
undetectable		 5vusA-3r6yA:
22.39
5vusB-3r6yA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W97_J_CHDJ101_1
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE
(Bacillus
licheniformis) 		4 / 5 TYR A 328
MET A 324
THR A 323
LEU A 320
 TYR  A 328 ( 1.3A)
MET  A 324 ( 0.0A)
THR  A 323 ( 0.8A)
LEU  A 320 ( 0.6A)
 1.15A 5w97J-5xluA:
undetectable		 5w97J-5xluA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X23_A_LSNA502_1
(CYTOCHROME P450 2C9)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		5 / 12 VAL A  69
MET A 167
GLY A 116
ALA A 115
LEU A  61
 VAL  A  69 ( 0.6A)
MET  A 167 ( 0.0A)
GLY  A 116 ( 0.0A)
ALA  A 115 ( 0.0A)
LEU  A  61 ( 0.6A)
 1.06A 5x23A-3h7aA:
undetectable		 5x23A-3h7aA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X2T_I_PEMI202_1
(HEMOGLOBIN SUBUNIT
ALPHA
HEMOGLOBIN SUBUNIT
BETA)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		4 / 8 ALA A  12
THR A  49
THR A  95
ALA A  67
 MET  A 600 (-3.8A)
None
None
None
 0.95A 5x2tI-2x1mA:
undetectable
5x2tJ-2x1mA:
undetectable
5x2tK-2x1mA:
undetectable
5x2tL-2x1mA:
undetectable		 5x2tI-2x1mA:
15.19
5x2tJ-2x1mA:
15.69
5x2tK-2x1mA:
15.19
5x2tL-2x1mA:
15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X2T_I_PEMI202_1
(HEMOGLOBIN SUBUNIT
ALPHA
HEMOGLOBIN SUBUNIT
BETA)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		4 / 8 ALA A  12
THR A  49
THR A  95
ALA A  68
 MET  A 600 (-3.8A)
None
None
None
 0.87A 5x2tI-2x1mA:
undetectable
5x2tJ-2x1mA:
undetectable
5x2tK-2x1mA:
undetectable
5x2tL-2x1mA:
undetectable		 5x2tI-2x1mA:
15.19
5x2tJ-2x1mA:
15.69
5x2tK-2x1mA:
15.19
5x2tL-2x1mA:
15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XXI_A_LSNA501_1
(CYTOCHROME P450 2C9)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		5 / 12 VAL A  69
MET A 167
GLY A 116
ALA A 115
LEU A  61
 VAL  A  69 ( 0.6A)
MET  A 167 ( 0.0A)
GLY  A 116 ( 0.0A)
ALA  A 115 ( 0.0A)
LEU  A  61 ( 0.6A)
 1.01A 5xxiA-3h7aA:
undetectable		 5xxiA-3h7aA:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_E_CHDE401_0
(BILE SALT HYDROLASE)		 3gxa OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 8 ILE A 192
ASN A 213
LEU A 158
LEU A 126
 None
MET  A 296 (-3.9A)
None
None
 0.83A 5y7pE-3gxaA:
undetectable		 5y7pE-3gxaA:
23.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_E_CHDE401_0
(BILE SALT HYDROLASE)		 3ir1 OUTER MEMBRANE
LIPOPROTEIN GNA1946
(Neisseria
meningitidis) 		4 / 8 ILE A 192
ASN A 213
LEU A 158
LEU A 126
 None
MET  A 600 (-3.9A)
None
None
 0.80A 5y7pE-3ir1A:
undetectable		 5y7pE-3ir1A:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YN6_A_SAMA401_0
(NSP16 PROTEIN)		 3r9r PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE
(Mycobacteroides
abscessus) 		5 / 12 GLY A 202
GLY A 207
ASP A 213
ASP A  94
MET A  95
 GLY  A 202 ( 0.0A)
GLY  A 207 ( 0.0A)
ASP  A 213 ( 0.6A)
ASP  A  94 ( 0.6A)
MET  A  95 ( 0.0A)
 1.36A 5yn6A-3r9rA:
undetectable		 5yn6A-3r9rA:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A93_B_8NUB3001_1
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 4io6 AVGLUR1 LIGAND
BINDING DOMAIN
(Adineta
vaga) 		4 / 5 ASP A  85
ILE A 209
ASN A  64
TYR A  67
 MET  A 301 (-4.7A)
None
None
MET  A 301 (-3.1A)
 0.98A 6a93B-4io6A:
undetectable		 6a93B-4io6A:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AP6_A_TLFA300_0
(PROBABLE
STRIGOLACTONE
ESTERASE DAD2)		 2ajh LEUCYL-TRNA
SYNTHETASE
(Escherichia
coli) 		5 / 12 PHE A 234
VAL A 236
VAL A 338
PHE A 253
VAL A 320
 None
None
MET  A 501 (-3.6A)
None
None
 1.19A 6ap6A-2ajhA:
undetectable		 6ap6A-2ajhA:
24.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AP6_B_TLFB300_0
(PROBABLE
STRIGOLACTONE
ESTERASE DAD2)		 2ajh LEUCYL-TRNA
SYNTHETASE
(Escherichia
coli) 		5 / 12 PHE A 234
VAL A 236
VAL A 338
PHE A 253
VAL A 320
 None
None
MET  A 501 (-3.6A)
None
None
 1.18A 6ap6B-2ajhA:
undetectable		 6ap6B-2ajhA:
24.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
 MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
 1.43A 6av1A-3r6yA:
undetectable
6av1B-3r6yA:
undetectable		 6av1A-3r6yA:
12.98
6av1B-3r6yA:
12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AYC_A_1YNA502_1
(PROTEIN CYP51)		 1wkm METHIONINE
AMINOPEPTIDASE
(Pyrococcus
furiosus) 		5 / 12 ALA A 110
PHE A  50
ALA A  49
ALA A  92
THR A 294
 None
MET  A1298 (-3.8A)
None
None
None
 1.21A 6aycA-1wkmA:
undetectable		 6aycA-1wkmA:
16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B0I_B_TA1B502_1
(TUBULIN BETA CHAIN)		 1p1m HYPOTHETICAL PROTEIN
TM0936
(Thermotoga
maritima) 		5 / 12 LEU A 193
ALA A 190
PRO A 172
GLY A 137
LEU A 138
 None
None
None
MET  A5001 ( 3.8A)
None
 1.04A 6b0iB-1p1mA:
undetectable		 6b0iB-1p1mA:
11.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BC9_A_ETSA302_2
(CARBONIC ANHYDRASE 2)		 1xs5 MEMBRANE LIPOPROTEIN
TPN32
(Treponema
pallidum) 		4 / 5 GLU A  87
HIS A  85
LEU A 204
VAL A  84
 MET  A 301 (-2.6A)
None
None
None
 1.05A 6bc9A-1xs5A:
undetectable		 6bc9A-1xs5A:
15.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CBD_A_TRPA902_0
(PROTEIN ARGONAUTE-2)		 3k2d ABC-TYPE METAL ION
TRANSPORT SYSTEM,
PERIPLASMIC
COMPONENT
(Vibrio
vulnificus) 		4 / 4 VAL A  70
ALA A  74
PHE A  86
PHE A  66
 None
None
MET  A 266 (-4.9A)
None
 1.33A 6cbdA-3k2dA:
undetectable		 6cbdA-3k2dA:
13.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CBD_A_TRPA902_0
(PROTEIN ARGONAUTE-2)		 4qhq LIPOPROTEIN
(Burkholderia
cenocepacia) 		4 / 4 VAL A  69
ALA A  73
PHE A  85
PHE A  65
 None
None
MET  A 301 (-4.7A)
None
 1.48A 6cbdA-4qhqA:
1.8		 6cbdA-4qhqA:
13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CBZ_B_ESTB602_1
(ESTROGEN RECEPTOR)		 5nfh METHIONYL-TRNA
SYNTHETASE, PUTATIVE
(Trypanosoma
brucei) 		5 / 10 LEU A 532
ALA A 529
LEU A 416
ILE A 542
HIS A 523
 None
None
None
None
MET  A 807 ( 4.7A)
 1.28A 6cbzB-5nfhA:
undetectable		 6cbzB-5nfhA:
9.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CNK_A_NCTA405_1
(NEURONAL
ACETYLCHOLINE
RECEPTOR SUBUNIT
ALPHA-4)		 2x1m METHIONYL-TRNA
SYNTHETASE
(Mycolicibacteriu
m
smegmatis) 		4 / 6 TYR A   6
THR A  47
TYR A 237
THR A  29
 None
None
MET  A 600 (-4.6A)
None
 1.03A 6cnkA-2x1mA:
3.6
6cnkB-2x1mA:
4.7		 6cnkA-2x1mA:
9.39
6cnkB-2x1mA:
9.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_1
(TYROSINE-PROTEIN
KINASE ABL1)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		4 / 5 VAL A  70
PHE A 460
MET A 459
GLY A 457
 VAL  A  70 ( 0.6A)
PHE  A 460 ( 1.3A)
MET  A 459 ( 0.0A)
GLY  A 457 ( 0.0A)
 1.40A 6hd4A-5nksA:
undetectable		 6hd4A-5nksA:
10.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HU9_T_PCFT101_0
(CYTOCHROME B-C1
COMPLEX SUBUNIT 1,
MITOCHONDRIAL
CYTOCHROME B-C1
COMPLEX SUBUNIT 9
CYTOCHROME B-C1
COMPLEX SUBUNIT
RIESKE,
MITOCHONDRIAL)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		5 / 10 SER A 286
MET A 280
GLY A 340
ALA A 178
ASN A 279
 SER  A 286 ( 0.0A)
MET  A 280 ( 0.0A)
GLY  A 340 ( 0.0A)
ALA  A 178 ( 0.0A)
ASN  A 279 ( 0.6A)
 1.35A 6hu9L-4g9kA:
undetectable
6hu9P-4g9kA:
undetectable
6hu9T-4g9kA:
undetectable		 6hu9L-4g9kA:
23.60
6hu9P-4g9kA:
16.74
6hu9T-4g9kA:
11.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6IE8_A_CHDA201_0
(REGULATORY PROTEIN)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		5 / 12 THR A 386
ILE A 256
TYR A 257
LEU A 534
MET A 538
 THR  A 386 ( 0.8A)
ILE  A 256 ( 0.7A)
TYR  A 257 ( 1.3A)
LEU  A 534 ( 0.6A)
MET  A 538 ( 0.0A)
 1.30A 6ie8A-2vbfA:
undetectable		 6ie8A-2vbfA:
14.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_J_CHDJ102_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE
(Bacillus
licheniformis) 		4 / 5 TYR A 328
MET A 324
THR A 323
LEU A 320
 TYR  A 328 ( 1.3A)
MET  A 324 ( 0.0A)
THR  A 323 ( 0.8A)
LEU  A 320 ( 0.6A)
 1.13A 6nknJ-5xluA:
undetectable		 6nknJ-5xluA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_W_CHDW102_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE
(Bacillus
licheniformis) 		4 / 5 TYR A 328
MET A 324
THR A 323
LEU A 320
 TYR  A 328 ( 1.3A)
MET  A 324 ( 0.0A)
THR  A 323 ( 0.8A)
LEU  A 320 ( 0.6A)
 1.14A 6nknW-5xluA:
undetectable		 6nknW-5xluA:
undetectable